JP2006517788A - １５９８６、２１８８、２０７４３、９１４８、９１５１、９７９１、４４２５２、１４１８４、４２４６１、８２０４、７９７０、２５５５２、２１６５７、２６４９２、２４１１、１５０８８、１９０５、２８８９９、６３３８０、３３９３５、１０４８０、１２６８６、２５５０１、１７６９４、１５７０１、５３０６２、４９９０８、２１６１２、３８９４９、６２１６、４６８６３、９２３５、２２０１、６９８５、９８８３、１２２３８、１８０５７、２１６１７、３９２２８、４９９２８、５４４７６、６２１１３、６４３１６、１２２６４、３２３６２、５８１９８、２８８７、３２０５、８５５７、９６００、９６９３、４４８６７、５３０５８、５５５５６、５７６５８、２２０８、１０２５２、１０３０２、１４２１８、３３８７７、１０３１７、１０４８５、２５９６４、１４８１５、１３６３、１３９７、１４８２７、２１７０８、３８０１、６４６９８、２１７９または１３２４９を使用する癌を処置するための方法および組成物 - Google Patents

Info

Publication number

JP2006517788A

JP2006517788A JP2005509989A JP2005509989A JP2006517788A JP 2006517788 A JP2006517788 A JP 2006517788A JP 2005509989 A JP2005509989 A JP 2005509989A JP 2005509989 A JP2005509989 A JP 2005509989A JP 2006517788 A JP2006517788 A JP 2006517788A

Authority

JP

Japan

Prior art keywords

antibody

cancer

colon

mrna

normal

Prior art date

2002-12-20

Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)

Pending

Links

• Espacenet
• Global Dossier
• Discuss

• 206010028980 Neoplasm Diseases 0.000 title claims abstract description 269
• 201000011510 cancer Diseases 0.000 title claims abstract description 85
• 238000000034 method Methods 0.000 title claims abstract description 57
• 239000000203 mixture Substances 0.000 title claims abstract description 5
• 208000029742 colonic neoplasm Diseases 0.000 claims abstract description 204
• 208000026310 Breast neoplasm Diseases 0.000 claims abstract description 143
• 208000020816 lung neoplasm Diseases 0.000 claims abstract description 100
• 206010061535 Ovarian neoplasm Diseases 0.000 claims abstract description 97
• 108090000765 processed proteins & peptides Proteins 0.000 claims abstract description 95
• 102000004196 processed proteins & peptides Human genes 0.000 claims abstract description 92
• 229920001184 polypeptide Polymers 0.000 claims abstract description 89
• 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims abstract description 75
• 206010006187 Breast cancer Diseases 0.000 claims abstract description 71
• 150000007523 nucleic acids Chemical class 0.000 claims abstract description 69
• 102000039446 nucleic acids Human genes 0.000 claims abstract description 69
• 108020004707 nucleic acids Proteins 0.000 claims abstract description 69
• 206010058467 Lung neoplasm malignant Diseases 0.000 claims abstract description 47
• 201000005202 lung cancer Diseases 0.000 claims abstract description 45
• 206010009944 Colon cancer Diseases 0.000 claims abstract description 43
• 206010033128 Ovarian cancer Diseases 0.000 claims abstract description 37
• 206010060862 Prostate cancer Diseases 0.000 claims abstract description 12
• 208000000236 Prostatic Neoplasms Diseases 0.000 claims abstract description 12
• 230000014509 gene expression Effects 0.000 claims description 354
• 230000000694 effects Effects 0.000 claims description 155
• 230000002491 angiogenic effect Effects 0.000 claims description 48
• 208000035475 disorder Diseases 0.000 claims description 34
• 230000027455 binding Effects 0.000 claims description 25
• 150000001875 compounds Chemical class 0.000 claims description 22
• 230000008569 process Effects 0.000 claims description 14
• 230000002159 abnormal effect Effects 0.000 claims description 12
• 150000003384 small molecules Chemical class 0.000 claims description 12
• 239000000758 substrate Substances 0.000 claims description 12
• 238000012360 testing method Methods 0.000 claims description 8
• 230000000711 cancerogenic effect Effects 0.000 claims description 6
• 230000000692 anti-sense effect Effects 0.000 claims description 4
• 239000012528 membrane Substances 0.000 claims description 3
• 238000003158 yeast two-hybrid assay Methods 0.000 claims description 3
• 238000009472 formulation Methods 0.000 claims description 2
• 238000012875 competitive assay Methods 0.000 claims 2
• 238000003018 immunoassay Methods 0.000 claims 2
• 230000001568 sexual effect Effects 0.000 claims 1
• 230000001965 increasing effect Effects 0.000 abstract description 217
• 238000011282 treatment Methods 0.000 abstract description 48
• 230000033115 angiogenesis Effects 0.000 abstract description 28
• 230000003247 decreasing effect Effects 0.000 abstract description 10
• 230000036952 cancer formation Effects 0.000 abstract description 8
• 230000001613 neoplastic effect Effects 0.000 abstract description 6
• 238000003745 diagnosis Methods 0.000 abstract description 4
• 108020004999 messenger RNA Proteins 0.000 description 449
• 210000001519 tissue Anatomy 0.000 description 268
• 210000001072 colon Anatomy 0.000 description 212
• 210000004027 cell Anatomy 0.000 description 184
• 208000037841 lung tumor Diseases 0.000 description 184
• 108090000623 proteins and genes Proteins 0.000 description 178
• 210000004072 lung Anatomy 0.000 description 161
• 238000004458 analytical method Methods 0.000 description 140
• 210000000481 breast Anatomy 0.000 description 91
• 235000018102 proteins Nutrition 0.000 description 80
• 102000004169 proteins and genes Human genes 0.000 description 80
• 239000000523 sample Substances 0.000 description 71
• 229940024606 amino acid Drugs 0.000 description 68
• 235000001014 amino acid Nutrition 0.000 description 67
• 150000001413 amino acids Chemical class 0.000 description 67
• 210000004185 liver Anatomy 0.000 description 64
• 230000006870 function Effects 0.000 description 63
• 206010027476 Metastases Diseases 0.000 description 61
• 108091026890 Coding region Proteins 0.000 description 60
• 108091023045 Untranslated Region Proteins 0.000 description 60
• 230000005764 inhibitory process Effects 0.000 description 60
• 239000002773 nucleotide Substances 0.000 description 60
• 125000003729 nucleotide group Chemical group 0.000 description 60
• 238000012216 screening Methods 0.000 description 59
• 230000009401 metastasis Effects 0.000 description 49
• 238000007901 in situ hybridization Methods 0.000 description 47
• 210000004924 lung microvascular endothelial cell Anatomy 0.000 description 45
• 210000004881 tumor cell Anatomy 0.000 description 43
• 201000010099 disease Diseases 0.000 description 40
• 210000002889 endothelial cell Anatomy 0.000 description 40
• 230000002611 ovarian Effects 0.000 description 36
• 238000002474 experimental method Methods 0.000 description 31
• 230000004614 tumor growth Effects 0.000 description 30
• 206010027457 Metastases to liver Diseases 0.000 description 28
• 210000004556 brain Anatomy 0.000 description 27
• 210000003734 kidney Anatomy 0.000 description 27
• 230000009467 reduction Effects 0.000 description 27
• 238000006722 reduction reaction Methods 0.000 description 27
• 230000009036 growth inhibition Effects 0.000 description 26
• 210000001672 ovary Anatomy 0.000 description 26
• 102000004190 Enzymes Human genes 0.000 description 25
• 108090000790 Enzymes Proteins 0.000 description 25
• 229940088598 enzyme Drugs 0.000 description 25
• 108091030071 RNAI Proteins 0.000 description 23
• 230000009368 gene silencing by RNA Effects 0.000 description 23
• 230000015572 biosynthetic process Effects 0.000 description 22
• 210000002216 heart Anatomy 0.000 description 20
• 230000002062 proliferating effect Effects 0.000 description 20
• 230000012010 growth Effects 0.000 description 19
• 230000035755 proliferation Effects 0.000 description 19
• 230000037361 pathway Effects 0.000 description 17
• 238000003556 assay Methods 0.000 description 16
• 230000001419 dependent effect Effects 0.000 description 16
• 230000010261 cell growth Effects 0.000 description 15
• 210000003754 fetus Anatomy 0.000 description 15
• 230000001338 necrotic effect Effects 0.000 description 15
• 230000006907 apoptotic process Effects 0.000 description 14
• 108091000080 Phosphotransferase Proteins 0.000 description 13
• 230000033228 biological regulation Effects 0.000 description 13
• 210000000267 erythroid cell Anatomy 0.000 description 13
• 230000002018 overexpression Effects 0.000 description 13
• 102000020233 phosphotransferase Human genes 0.000 description 13
• 239000003814 drug Substances 0.000 description 12
• 206010061289 metastatic neoplasm Diseases 0.000 description 12
• 238000001890 transfection Methods 0.000 description 12
• 230000005747 tumor angiogenesis Effects 0.000 description 12
• 230000004663 cell proliferation Effects 0.000 description 11
• 230000001605 fetal effect Effects 0.000 description 11
• 230000001105 regulatory effect Effects 0.000 description 11
• 210000002027 skeletal muscle Anatomy 0.000 description 11
• 230000004565 tumor cell growth Effects 0.000 description 11
• 210000003606 umbilical vein Anatomy 0.000 description 11
• 102000006589 Alpha-ketoglutarate dehydrogenase Human genes 0.000 description 10
• 108020004306 Alpha-ketoglutarate dehydrogenase Proteins 0.000 description 10
• 102000003688 G-Protein-Coupled Receptors Human genes 0.000 description 10
• 108090000045 G-Protein-Coupled Receptors Proteins 0.000 description 10
• 101000945093 Homo sapiens Ribosomal protein S6 kinase alpha-4 Proteins 0.000 description 10
• 108700020796 Oncogene Proteins 0.000 description 10
• 108091005804 Peptidases Proteins 0.000 description 10
• 102100033644 Ribosomal protein S6 kinase alpha-4 Human genes 0.000 description 10
• 102100030071 Serine/threonine-protein kinase Sgk3 Human genes 0.000 description 10
• 210000003169 central nervous system Anatomy 0.000 description 10
• 201000011066 hemangioma Diseases 0.000 description 10
• 239000003112 inhibitor Substances 0.000 description 10
• 230000004060 metabolic process Effects 0.000 description 10
• 108010001058 Acyl-CoA Dehydrogenase Proteins 0.000 description 9
• 102000002735 Acyl-CoA Dehydrogenase Human genes 0.000 description 9
• 201000009030 Carcinoma Diseases 0.000 description 9
• 101710088194 Dehydrogenase Proteins 0.000 description 9
• 102000035195 Peptidases Human genes 0.000 description 9
• RADKZDMFGJYCBB-UHFFFAOYSA-N Pyridoxal Chemical compound CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 description 9
• 108020004459 Small interfering RNA Proteins 0.000 description 9
• 208000008383 Wilms tumor Diseases 0.000 description 9
• 230000004913 activation Effects 0.000 description 9
• 208000009956 adenocarcinoma Diseases 0.000 description 9
• 208000030533 eye disease Diseases 0.000 description 9
• 230000037311 normal skin Effects 0.000 description 9
• 239000000047 product Substances 0.000 description 9
• 230000011664 signaling Effects 0.000 description 9
• 229940124597 therapeutic agent Drugs 0.000 description 9
• 102100036409 Activated CDC42 kinase 1 Human genes 0.000 description 8
• 102100025064 Cellular tumor antigen p53 Human genes 0.000 description 8
• 208000001333 Colorectal Neoplasms Diseases 0.000 description 8
• 101000928956 Homo sapiens Activated CDC42 kinase 1 Proteins 0.000 description 8
• 101000721661 Homo sapiens Cellular tumor antigen p53 Proteins 0.000 description 8
• 102100039792 Oxidized purine nucleoside triphosphate hydrolase Human genes 0.000 description 8
• 102000004316 Oxidoreductases Human genes 0.000 description 8
• 108090000854 Oxidoreductases Proteins 0.000 description 8
• 108090000430 Phosphatidylinositol 3-kinases Proteins 0.000 description 8
• 102000003993 Phosphatidylinositol 3-kinases Human genes 0.000 description 8
• 210000004204 blood vessel Anatomy 0.000 description 8
• 230000007423 decrease Effects 0.000 description 8
• 230000005012 migration Effects 0.000 description 8
• 238000013508 migration Methods 0.000 description 8
• 201000008026 nephroblastoma Diseases 0.000 description 8
• 210000000496 pancreas Anatomy 0.000 description 8
• 230000026731 phosphorylation Effects 0.000 description 8
• 238000006366 phosphorylation reaction Methods 0.000 description 8
• 210000002307 prostate Anatomy 0.000 description 8
• LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 description 8
• 230000002829 reductive effect Effects 0.000 description 8
• PORPENFLTBBHSG-MGBGTMOVSA-N 1,2-dihexadecanoyl-sn-glycerol-3-phosphate Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP(O)(O)=O)OC(=O)CCCCCCCCCCCCCCC PORPENFLTBBHSG-MGBGTMOVSA-N 0.000 description 7
• 102100031765 3-beta-hydroxysteroid-Delta(8),Delta(7)-isomerase Human genes 0.000 description 7
• 101000864800 Homo sapiens Serine/threonine-protein kinase Sgk1 Proteins 0.000 description 7
• 102000004157 Hydrolases Human genes 0.000 description 7
• 108090000604 Hydrolases Proteins 0.000 description 7
• 102100037694 Kinesin-like protein KIF20A Human genes 0.000 description 7
• 108050006127 Kinesin-like protein KIF20A Proteins 0.000 description 7
• 102100023426 Kinesin-like protein KIF2A Human genes 0.000 description 7
• 108060004795 Methyltransferase Proteins 0.000 description 7
• 108091034117 Oligonucleotide Proteins 0.000 description 7
• 102100030070 Serine/threonine-protein kinase Sgk1 Human genes 0.000 description 7
• 101710158594 Serine/threonine-protein kinase Sgk3 Proteins 0.000 description 7
• 210000004100 adrenal gland Anatomy 0.000 description 7
• 210000000981 epithelium Anatomy 0.000 description 7
• 238000000338 in vitro Methods 0.000 description 7
• 230000001394 metastastic effect Effects 0.000 description 7
• 210000000963 osteoblast Anatomy 0.000 description 7
• 210000000329 smooth muscle myocyte Anatomy 0.000 description 7
• 230000004083 survival effect Effects 0.000 description 7
• 230000032258 transport Effects 0.000 description 7
• WRGQSWVCFNIUNZ-GDCKJWNLSA-N 1-oleoyl-sn-glycerol 3-phosphate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OC[C@@H](O)COP(O)(O)=O WRGQSWVCFNIUNZ-GDCKJWNLSA-N 0.000 description 6
• 101710204697 3-beta-hydroxysteroid-Delta(8),Delta(7)-isomerase Proteins 0.000 description 6
• 108010005525 8-oxodGTPase Proteins 0.000 description 6
• 208000003200 Adenoma Diseases 0.000 description 6
• 208000005623 Carcinogenesis Diseases 0.000 description 6
• 102000005636 Cyclic AMP Response Element-Binding Protein Human genes 0.000 description 6
• 108010045171 Cyclic AMP Response Element-Binding Protein Proteins 0.000 description 6
• 101001050577 Homo sapiens Kinesin-like protein KIF2A Proteins 0.000 description 6
• 102000010638 Kinesin Human genes 0.000 description 6
• 108010063296 Kinesin Proteins 0.000 description 6
• 108010009384 L-Iditol 2-Dehydrogenase Proteins 0.000 description 6
• 102000018653 Long-Chain Acyl-CoA Dehydrogenase Human genes 0.000 description 6
• 108010027062 Long-Chain Acyl-CoA Dehydrogenase Proteins 0.000 description 6
• 102000029749 Microtubule Human genes 0.000 description 6
• 108091022875 Microtubule Proteins 0.000 description 6
• 102000004960 NAD(P)H dehydrogenase (quinone) Human genes 0.000 description 6
• 108020000284 NAD(P)H dehydrogenase (quinone) Proteins 0.000 description 6
• 206010061309 Neoplasm progression Diseases 0.000 description 6
• 206010029113 Neovascularisation Diseases 0.000 description 6
• 102100033237 Pro-epidermal growth factor Human genes 0.000 description 6
• 102100026974 Sorbitol dehydrogenase Human genes 0.000 description 6
• AWUCVROLDVIAJX-UHFFFAOYSA-N alpha-glycerophosphate Natural products OCC(O)COP(O)(O)=O AWUCVROLDVIAJX-UHFFFAOYSA-N 0.000 description 6
• 239000002246 antineoplastic agent Substances 0.000 description 6
• 229940041181 antineoplastic drug Drugs 0.000 description 6
• 210000001736 capillary Anatomy 0.000 description 6
• 231100000504 carcinogenesis Toxicity 0.000 description 6
• 230000030833 cell death Effects 0.000 description 6
• 230000024245 cell differentiation Effects 0.000 description 6
• 210000003016 hypothalamus Anatomy 0.000 description 6
• 210000005228 liver tissue Anatomy 0.000 description 6
• 210000004688 microtubule Anatomy 0.000 description 6
• 230000014616 translation Effects 0.000 description 6
• 230000005751 tumor progression Effects 0.000 description 6
• 231100000588 tumorigenic Toxicity 0.000 description 6
• 230000000381 tumorigenic effect Effects 0.000 description 6
• 230000003827 upregulation Effects 0.000 description 6
• 108091032973 (ribonucleotides)n+m Proteins 0.000 description 5
• 108010024223 Adenine phosphoribosyltransferase Proteins 0.000 description 5
• 239000004475 Arginine Substances 0.000 description 5
• 102000051366 Glycosyltransferases Human genes 0.000 description 5
• 108700023372 Glycosyltransferases Proteins 0.000 description 5
• 102100027489 Helicase-like transcription factor Human genes 0.000 description 5
• 102000043136 MAP kinase family Human genes 0.000 description 5
• 108091054455 MAP kinase family Proteins 0.000 description 5
• 102100026840 Serine/threonine-protein kinase PAK 6 Human genes 0.000 description 5
• 102000004357 Transferases Human genes 0.000 description 5
• 108090000992 Transferases Proteins 0.000 description 5
• ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 5
• 230000008901 benefit Effects 0.000 description 5
• 230000015556 catabolic process Effects 0.000 description 5
• 102000013515 cdc42 GTP-Binding Protein Human genes 0.000 description 5
• 108010051348 cdc42 GTP-Binding Protein Proteins 0.000 description 5
• 230000022131 cell cycle Effects 0.000 description 5
• 238000003776 cleavage reaction Methods 0.000 description 5
• 230000021953 cytokinesis Effects 0.000 description 5
• 235000014113 dietary fatty acids Nutrition 0.000 description 5
• 229930195729 fatty acid Natural products 0.000 description 5
• 239000000194 fatty acid Substances 0.000 description 5
• 150000004665 fatty acids Chemical class 0.000 description 5
• 206010020718 hyperplasia Diseases 0.000 description 5
• 230000000977 initiatory effect Effects 0.000 description 5
• 208000014018 liver neoplasm Diseases 0.000 description 5
• 229910052751 metal Inorganic materials 0.000 description 5
• 239000002184 metal Substances 0.000 description 5
• 239000003226 mitogen Substances 0.000 description 5
• 230000011278 mitosis Effects 0.000 description 5
• 238000007254 oxidation reaction Methods 0.000 description 5
• 108060006633 protein kinase Proteins 0.000 description 5
• 230000002685 pulmonary effect Effects 0.000 description 5
• 102000005962 receptors Human genes 0.000 description 5
• 108020003175 receptors Proteins 0.000 description 5
• 230000007017 scission Effects 0.000 description 5
• 206010041823 squamous cell carcinoma Diseases 0.000 description 5
• -1 subfamily a Proteins 0.000 description 5
• 210000003437 trachea Anatomy 0.000 description 5
• 102100029457 Adenine phosphoribosyltransferase Human genes 0.000 description 4
• 201000001320 Atherosclerosis Diseases 0.000 description 4
• 102000000584 Calmodulin Human genes 0.000 description 4
• 108010041952 Calmodulin Proteins 0.000 description 4
• 108090000489 Carboxy-Lyases Proteins 0.000 description 4
• 102000004127 Cytokines Human genes 0.000 description 4
• 108090000695 Cytokines Proteins 0.000 description 4
• 201000009273 Endometriosis Diseases 0.000 description 4
• 206010019695 Hepatic neoplasm Diseases 0.000 description 4
• 101001081105 Homo sapiens Helicase-like transcription factor Proteins 0.000 description 4
• 208000008839 Kidney Neoplasms Diseases 0.000 description 4
• 101150105104 Kras gene Proteins 0.000 description 4
• 206010027458 Metastases to lung Diseases 0.000 description 4
• 108010003060 Methionine-tRNA ligase Proteins 0.000 description 4
• 102000000362 Methionyl-tRNA synthetases Human genes 0.000 description 4
• 108010052185 Myotonin-Protein Kinase Proteins 0.000 description 4
• 102100022437 Myotonin-protein kinase Human genes 0.000 description 4
• 101710167853 N-methyltransferase Proteins 0.000 description 4
• 208000022873 Ocular disease Diseases 0.000 description 4
• 108091007960 PI3Ks Proteins 0.000 description 4
• 239000004365 Protease Substances 0.000 description 4
• 102000001253 Protein Kinase Human genes 0.000 description 4
• 201000004681 Psoriasis Diseases 0.000 description 4
• 102000042463 Rho family Human genes 0.000 description 4
• 108091078243 Rho family Proteins 0.000 description 4
• 206010039491 Sarcoma Diseases 0.000 description 4
• 102100030267 Serine/threonine-protein kinase PLK4 Human genes 0.000 description 4
• 101710142587 Short-chain dehydrogenase/reductase Proteins 0.000 description 4
• 229930182558 Sterol Natural products 0.000 description 4
• 210000001367 artery Anatomy 0.000 description 4
• 208000035269 cancer or benign tumor Diseases 0.000 description 4
• 230000000747 cardiac effect Effects 0.000 description 4
• 208000037976 chronic inflammation Diseases 0.000 description 4
• 208000037893 chronic inflammatory disorder Diseases 0.000 description 4
• 238000011161 development Methods 0.000 description 4
• 230000018109 developmental process Effects 0.000 description 4
• 230000004069 differentiation Effects 0.000 description 4
• 210000002919 epithelial cell Anatomy 0.000 description 4
• 230000002390 hyperplastic effect Effects 0.000 description 4
• 230000003463 hyperproliferative effect Effects 0.000 description 4
• 230000002401 inhibitory effect Effects 0.000 description 4
• 208000023589 ischemic disease Diseases 0.000 description 4
• 238000004519 manufacturing process Methods 0.000 description 4
• 230000007246 mechanism Effects 0.000 description 4
• 201000001441 melanoma Diseases 0.000 description 4
• 230000000394 mitotic effect Effects 0.000 description 4
• 230000005959 oncogenic signaling Effects 0.000 description 4
• 230000036542 oxidative stress Effects 0.000 description 4
• 229910052760 oxygen Inorganic materials 0.000 description 4
• 239000001301 oxygen Substances 0.000 description 4
• 230000001575 pathological effect Effects 0.000 description 4
• 208000014081 polyp of colon Diseases 0.000 description 4
• 208000023958 prostate neoplasm Diseases 0.000 description 4
• 230000004044 response Effects 0.000 description 4
• 235000003702 sterols Nutrition 0.000 description 4
• 238000013518 transcription Methods 0.000 description 4
• 230000035897 transcription Effects 0.000 description 4
• 238000013519 translation Methods 0.000 description 4
• 229940011671 vitamin b6 Drugs 0.000 description 4
• 102000057234 Acyl transferases Human genes 0.000 description 3
• 108700016155 Acyl transferases Proteins 0.000 description 3
• 206010001233 Adenoma benign Diseases 0.000 description 3
• 208000023328 Basedow disease Diseases 0.000 description 3
• 102000014914 Carrier Proteins Human genes 0.000 description 3
• 108090000994 Catalytic RNA Proteins 0.000 description 3
• 102000053642 Catalytic RNA Human genes 0.000 description 3
• 102100028757 Chondroitin sulfate proteoglycan 4 Human genes 0.000 description 3
• 108010077544 Chromatin Proteins 0.000 description 3
• GSXOAOHZAIYLCY-UHFFFAOYSA-N D-F6P Natural products OCC(=O)C(O)C(O)C(O)COP(O)(O)=O GSXOAOHZAIYLCY-UHFFFAOYSA-N 0.000 description 3
• 206010012689 Diabetic retinopathy Diseases 0.000 description 3
• IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 3
• 208000015023 Graves' disease Diseases 0.000 description 3
• UYTPUPDQBNUYGX-UHFFFAOYSA-N Guanine Natural products O=C1NC(N)=NC2=C1N=CN2 UYTPUPDQBNUYGX-UHFFFAOYSA-N 0.000 description 3
• 241000282412 Homo Species 0.000 description 3
• 101000916489 Homo sapiens Chondroitin sulfate proteoglycan 4 Proteins 0.000 description 3
• 101000983111 Homo sapiens Serine/threonine-protein kinase PAK 6 Proteins 0.000 description 3
• 101000864806 Homo sapiens Serine/threonine-protein kinase Sgk2 Proteins 0.000 description 3
• 101000864831 Homo sapiens Serine/threonine-protein kinase Sgk3 Proteins 0.000 description 3
• 101000716763 Homo sapiens Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial Proteins 0.000 description 3
• 102000004218 Insulin-Like Growth Factor I Human genes 0.000 description 3
• 108090000723 Insulin-Like Growth Factor I Proteins 0.000 description 3
• 102000004195 Isomerases Human genes 0.000 description 3
• 108090000769 Isomerases Proteins 0.000 description 3
• OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 3
• 102000003960 Ligases Human genes 0.000 description 3
• 108090000364 Ligases Proteins 0.000 description 3
• 206010027454 Metastases to breast Diseases 0.000 description 3
• 102000016397 Methyltransferase Human genes 0.000 description 3
• 102100025180 Mitogen-activated protein kinase kinase kinase 12 Human genes 0.000 description 3
• 241000699666 Mus <mouse, genus> Species 0.000 description 3
• 102000011420 Phospholipase D Human genes 0.000 description 3
• 108090000553 Phospholipase D Proteins 0.000 description 3
• 108010064209 Phosphoribosylglycinamide formyltransferase Proteins 0.000 description 3
• 108010073135 Phosphorylases Proteins 0.000 description 3
• 102000009097 Phosphorylases Human genes 0.000 description 3
• 108010070648 Pyridoxal Kinase Proteins 0.000 description 3
• 102000004477 Pyridoxine kinase Human genes 0.000 description 3
• 108090000944 RNA Helicases Proteins 0.000 description 3
• 102000004409 RNA Helicases Human genes 0.000 description 3
• 201000000582 Retinoblastoma Diseases 0.000 description 3
• 101710148161 Serine/threonine-protein kinase PAK 6 Proteins 0.000 description 3
• 102100031463 Serine/threonine-protein kinase PLK1 Human genes 0.000 description 3
• 102100020868 Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial Human genes 0.000 description 3
• 102000003929 Transaminases Human genes 0.000 description 3
• 108090000340 Transaminases Proteins 0.000 description 3
• 101710159648 Uncharacterized protein Proteins 0.000 description 3
• HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 3
• UPHPWXPNZIOZJL-UYSNGIAKSA-N [(2s,3r,5s,6r)-2,3,4,5,6-pentaphosphonooxycyclohexyl] phosphono hydrogen phosphate Chemical compound OP(O)(=O)OC1[C@H](OP(O)(O)=O)[C@@H](OP(O)(O)=O)C(OP(O)(=O)OP(O)(O)=O)[C@@H](OP(O)(O)=O)[C@@H]1OP(O)(O)=O UPHPWXPNZIOZJL-UYSNGIAKSA-N 0.000 description 3
• 210000002469 basement membrane Anatomy 0.000 description 3
• BGWGXPAPYGQALX-ARQDHWQXSA-N beta-D-fructofuranose 6-phosphate Chemical compound OC[C@@]1(O)O[C@H](COP(O)(O)=O)[C@@H](O)[C@@H]1O BGWGXPAPYGQALX-ARQDHWQXSA-N 0.000 description 3
• 210000004369 blood Anatomy 0.000 description 3
• 239000008280 blood Substances 0.000 description 3
• 239000012830 cancer therapeutic Substances 0.000 description 3
• 150000001720 carbohydrates Chemical class 0.000 description 3
• 235000014633 carbohydrates Nutrition 0.000 description 3
• 230000006369 cell cycle progression Effects 0.000 description 3
• 230000003915 cell function Effects 0.000 description 3
• 238000006243 chemical reaction Methods 0.000 description 3
• 229960001231 choline Drugs 0.000 description 3
• 210000003483 chromatin Anatomy 0.000 description 3
• DQLATGHUWYMOKM-UHFFFAOYSA-L cisplatin Chemical compound N[Pt](N)(Cl)Cl DQLATGHUWYMOKM-UHFFFAOYSA-L 0.000 description 3
• 201000010897 colon adenocarcinoma Diseases 0.000 description 3
• 230000000112 colonic effect Effects 0.000 description 3
• 238000006731 degradation reaction Methods 0.000 description 3
• 150000001982 diacylglycerols Chemical class 0.000 description 3
• 102000004419 dihydrofolate reductase Human genes 0.000 description 3
• 229940079593 drug Drugs 0.000 description 3
• 238000009510 drug design Methods 0.000 description 3
• 210000002472 endoplasmic reticulum Anatomy 0.000 description 3
• 210000003743 erythrocyte Anatomy 0.000 description 3
• 238000001415 gene therapy Methods 0.000 description 3
• 230000004153 glucose metabolism Effects 0.000 description 3
• 230000013595 glycosylation Effects 0.000 description 3
• 239000003102 growth factor Substances 0.000 description 3
• 210000005003 heart tissue Anatomy 0.000 description 3
• 239000005556 hormone Substances 0.000 description 3
• 229940088597 hormone Drugs 0.000 description 3
• 238000012613 in situ experiment Methods 0.000 description 3
• 208000015181 infectious disease Diseases 0.000 description 3
• 230000003993 interaction Effects 0.000 description 3
• 230000003834 intracellular effect Effects 0.000 description 3
• 230000009545 invasion Effects 0.000 description 3
• 150000002576 ketones Chemical class 0.000 description 3
• 230000004807 localization Effects 0.000 description 3
• 230000003211 malignant effect Effects 0.000 description 3
• 210000001161 mammalian embryo Anatomy 0.000 description 3
• 108010082117 matrigel Proteins 0.000 description 3
• 210000003593 megakaryocyte Anatomy 0.000 description 3
• 230000002503 metabolic effect Effects 0.000 description 3
• 108090001035 mitogen-activated protein kinase kinase kinase 12 Proteins 0.000 description 3
• 210000003205 muscle Anatomy 0.000 description 3
• 230000001817 pituitary effect Effects 0.000 description 3
• 108010056274 polo-like kinase 1 Proteins 0.000 description 3
• 229920005862 polyol Polymers 0.000 description 3
• 150000003077 polyols Chemical class 0.000 description 3
• 239000013641 positive control Substances 0.000 description 3
• 201000001514 prostate carcinoma Diseases 0.000 description 3
• 235000019419 proteases Nutrition 0.000 description 3
• 229960003581 pyridoxal Drugs 0.000 description 3
• 235000008164 pyridoxal Nutrition 0.000 description 3
• 239000011674 pyridoxal Substances 0.000 description 3
• 210000005084 renal tissue Anatomy 0.000 description 3
• 238000011160 research Methods 0.000 description 3
• 230000000284 resting effect Effects 0.000 description 3
• 206010039073 rheumatoid arthritis Diseases 0.000 description 3
• 108091092562 ribozyme Proteins 0.000 description 3
• 210000002966 serum Anatomy 0.000 description 3
• 230000019491 signal transduction Effects 0.000 description 3
• 208000000649 small cell carcinoma Diseases 0.000 description 3
• 208000000587 small cell lung carcinoma Diseases 0.000 description 3
• 230000004936 stimulating effect Effects 0.000 description 3
• 230000000638 stimulation Effects 0.000 description 3
• 230000035882 stress Effects 0.000 description 3
• 229940124598 therapeutic candidate Drugs 0.000 description 3
• 230000002103 transcriptional effect Effects 0.000 description 3
• 238000012085 transcriptional profiling Methods 0.000 description 3
• 230000009466 transformation Effects 0.000 description 3
• 238000011269 treatment regimen Methods 0.000 description 3
• 230000004102 tricarboxylic acid cycle Effects 0.000 description 3
• OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 3
• 210000003954 umbilical cord Anatomy 0.000 description 3
• 206010046766 uterine cancer Diseases 0.000 description 3
• 239000013598 vector Substances 0.000 description 3
• 235000019158 vitamin B6 Nutrition 0.000 description 3
• 239000011726 vitamin B6 Substances 0.000 description 3
• 239000011701 zinc Substances 0.000 description 3
• 229910052725 zinc Inorganic materials 0.000 description 3
• YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
• AZQWKYJCGOJGHM-UHFFFAOYSA-N 1,4-benzoquinone Chemical compound O=C1C=CC(=O)C=C1 AZQWKYJCGOJGHM-UHFFFAOYSA-N 0.000 description 2
• 102000004223 1-acyl-sn-glycerol-3-phosphate acyltransferase Human genes 0.000 description 2
• 102100026936 2-oxoglutarate dehydrogenase, mitochondrial Human genes 0.000 description 2
• 102100030162 2-oxoglutarate dehydrogenase-like, mitochondrial Human genes 0.000 description 2
• KDCGOANMDULRCW-UHFFFAOYSA-N 7H-purine Chemical compound N1=CNC2=NC=NC2=C1 KDCGOANMDULRCW-UHFFFAOYSA-N 0.000 description 2
• BUZOGVVQWCXXDP-VPENINKCSA-N 8-oxo-dGTP Chemical compound O=C1NC=2C(=O)NC(N)=NC=2N1[C@H]1C[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 BUZOGVVQWCXXDP-VPENINKCSA-N 0.000 description 2
• 208000010507 Adenocarcinoma of Lung Diseases 0.000 description 2
• 108010021809 Alcohol dehydrogenase Proteins 0.000 description 2
• 102000007698 Alcohol dehydrogenase Human genes 0.000 description 2
• 102000052866 Amino Acyl-tRNA Synthetases Human genes 0.000 description 2
• 108700028939 Amino Acyl-tRNA Synthetases Proteins 0.000 description 2
• 102100024507 BMP-2-inducible protein kinase Human genes 0.000 description 2
• 201000004569 Blindness Diseases 0.000 description 2
• 208000003174 Brain Neoplasms Diseases 0.000 description 2
• 108010068197 Butyryl-CoA Dehydrogenase Proteins 0.000 description 2
• RZZPDXZPRHQOCG-OJAKKHQRSA-M CDP-choline(1-) Chemical compound O[C@@H]1[C@H](O)[C@@H](COP([O-])(=O)OP([O-])(=O)OCC[N+](C)(C)C)O[C@H]1N1C(=O)N=C(N)C=C1 RZZPDXZPRHQOCG-OJAKKHQRSA-M 0.000 description 2
• 229940124638 COX inhibitor Drugs 0.000 description 2
• 108010003764 Calcium-Calmodulin-Dependent Protein Kinase Type 1 Proteins 0.000 description 2
• 102100033088 Calcium/calmodulin-dependent protein kinase type 1D Human genes 0.000 description 2
• CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
• 108010012236 Chemokines Proteins 0.000 description 2
• 102000019034 Chemokines Human genes 0.000 description 2
• 208000006332 Choriocarcinoma Diseases 0.000 description 2
• 108020004414 DNA Proteins 0.000 description 2
• 230000005778 DNA damage Effects 0.000 description 2
• 231100000277 DNA damage Toxicity 0.000 description 2
• 230000033616 DNA repair Effects 0.000 description 2
• 102100030011 Endoribonuclease Human genes 0.000 description 2
• 101710199605 Endoribonuclease Proteins 0.000 description 2
• 102000018233 Fibroblast Growth Factor Human genes 0.000 description 2
• 108050007372 Fibroblast Growth Factor Proteins 0.000 description 2
• 102100035421 Forkhead box protein O3 Human genes 0.000 description 2
• 102000030782 GTP binding Human genes 0.000 description 2
• 108091000058 GTP-Binding Proteins 0.000 description 2
• 208000010412 Glaucoma Diseases 0.000 description 2
• 208000032612 Glial tumor Diseases 0.000 description 2
• 206010018338 Glioma Diseases 0.000 description 2
• WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
• 102100023518 Glutamine-dependent NAD(+) synthetase Human genes 0.000 description 2
• 102000019058 Glycogen Synthase Kinase 3 beta Human genes 0.000 description 2
• 108010051975 Glycogen Synthase Kinase 3 beta Proteins 0.000 description 2
• 229920002683 Glycosaminoglycan Polymers 0.000 description 2
• 101000982656 Homo sapiens 2-oxoglutarate dehydrogenase, mitochondrial Proteins 0.000 description 2
• 101000877681 Homo sapiens Forkhead box protein O3 Proteins 0.000 description 2
• 101001112831 Homo sapiens Glutamine-dependent NAD(+) synthetase Proteins 0.000 description 2
• 101000599951 Homo sapiens Insulin-like growth factor I Proteins 0.000 description 2
• 101001018157 Homo sapiens Mitogen-activated protein kinase kinase kinase 20 Proteins 0.000 description 2
• 101000744394 Homo sapiens Oxidized purine nucleoside triphosphate hydrolase Proteins 0.000 description 2
• 101000870734 Homo sapiens Probable ATP-dependent RNA helicase DDX31 Proteins 0.000 description 2
• MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 2
• 206010020751 Hypersensitivity Diseases 0.000 description 2
• 206010062767 Hypophysitis Diseases 0.000 description 2
• 102100037852 Insulin-like growth factor I Human genes 0.000 description 2
• 108010055717 JNK Mitogen-Activated Protein Kinases Proteins 0.000 description 2
• 102000019145 JUN kinase activity proteins Human genes 0.000 description 2
• 102100027631 Kinesin-like protein KIF14 Human genes 0.000 description 2
• 101710134403 Kinesin-like protein KIF14 Proteins 0.000 description 2
• ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 description 2
• LCGISIDBXHGCDW-VKHMYHEASA-N L-glutamine amide Chemical compound NC(=O)[C@@H](N)CCC(N)=O LCGISIDBXHGCDW-VKHMYHEASA-N 0.000 description 2
• WZNJWVWKTVETCG-YFKPBYRVSA-N L-mimosine Chemical compound OC(=O)[C@@H](N)CN1C=CC(=O)C(O)=C1 WZNJWVWKTVETCG-YFKPBYRVSA-N 0.000 description 2
• 206010025323 Lymphomas Diseases 0.000 description 2
• 102100037611 Lysophospholipase Human genes 0.000 description 2
• 102000019149 MAP kinase activity proteins Human genes 0.000 description 2
• 108040008097 MAP kinase activity proteins Proteins 0.000 description 2
• 101150043871 MAPK7 gene Proteins 0.000 description 2
• 208000007054 Medullary Carcinoma Diseases 0.000 description 2
• 108010006035 Metalloproteases Proteins 0.000 description 2
• 102000005741 Metalloproteases Human genes 0.000 description 2
• 108010085747 Methylmalonyl-CoA Decarboxylase Proteins 0.000 description 2
• 102100023482 Mitogen-activated protein kinase 14 Human genes 0.000 description 2
• 206010068871 Myotonic dystrophy Diseases 0.000 description 2
• 102100022365 NAD(P)H dehydrogenase [quinone] 1 Human genes 0.000 description 2
• 101710095135 NAD(P)H dehydrogenase [quinone] 1 Proteins 0.000 description 2
• 208000034176 Neoplasms, Germ Cell and Embryonal Diseases 0.000 description 2
• 229930012538 Paclitaxel Natural products 0.000 description 2
• 206010061902 Pancreatic neoplasm Diseases 0.000 description 2
• 102100039654 Phosphoribosylglycinamide formyltransferase Human genes 0.000 description 2
• 208000002151 Pleural effusion Diseases 0.000 description 2
• 208000037062 Polyps Diseases 0.000 description 2
• 102100033401 Probable ATP-dependent RNA helicase DDX31 Human genes 0.000 description 2
• 102000004879 Racemases and epimerases Human genes 0.000 description 2
• 108090001066 Racemases and epimerases Proteins 0.000 description 2
• 102100027551 Ras-specific guanine nucleotide-releasing factor 1 Human genes 0.000 description 2
• 241000700159 Rattus Species 0.000 description 2
• 102000012464 Retinol dehydrogenase 10 Human genes 0.000 description 2
• 108050002017 Retinol dehydrogenase 10 Proteins 0.000 description 2
• 101710113029 Serine/threonine-protein kinase Proteins 0.000 description 2
• 102100037959 Serine/threonine-protein kinase 17B Human genes 0.000 description 2
• 208000000453 Skin Neoplasms Diseases 0.000 description 2
• 206010041067 Small cell lung cancer Diseases 0.000 description 2
• 102220497176 Small vasohibin-binding protein_T47D_mutation Human genes 0.000 description 2
• 206010043276 Teratoma Diseases 0.000 description 2
• 208000024313 Testicular Neoplasms Diseases 0.000 description 2
• 108700007696 Tetrahydrofolate Dehydrogenase Proteins 0.000 description 2
• 108010022394 Threonine synthase Proteins 0.000 description 2
• IQFYYKKMVGJFEH-XLPZGREQSA-N Thymidine Chemical compound O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](CO)[C@@H](O)C1 IQFYYKKMVGJFEH-XLPZGREQSA-N 0.000 description 2
• 102000040945 Transcription factor Human genes 0.000 description 2
• 108091023040 Transcription factor Proteins 0.000 description 2
• 108060008682 Tumor Necrosis Factor Proteins 0.000 description 2
• 102000000852 Tumor Necrosis Factor-alpha Human genes 0.000 description 2
• LFTYTUAZOPRMMI-CFRASDGPSA-N UDP-N-acetyl-alpha-D-glucosamine Chemical compound O1[C@H](CO)[C@@H](O)[C@H](O)[C@@H](NC(=O)C)[C@H]1OP(O)(=O)OP(O)(=O)OC[C@@H]1[C@@H](O)[C@@H](O)[C@H](N2C(NC(=O)C=C2)=O)O1 LFTYTUAZOPRMMI-CFRASDGPSA-N 0.000 description 2
• LFTYTUAZOPRMMI-UHFFFAOYSA-N UNPD164450 Natural products O1C(CO)C(O)C(O)C(NC(=O)C)C1OP(O)(=O)OP(O)(=O)OCC1C(O)C(O)C(N2C(NC(=O)C=C2)=O)O1 LFTYTUAZOPRMMI-UHFFFAOYSA-N 0.000 description 2
• 208000002495 Uterine Neoplasms Diseases 0.000 description 2
• 206010046851 Uveitis Diseases 0.000 description 2
• 102000013814 Wnt Human genes 0.000 description 2
• 108050003627 Wnt Proteins 0.000 description 2
• 201000006878 X-linked chondrodysplasia punctata 2 Diseases 0.000 description 2
• ZSLZBFCDCINBPY-ZSJPKINUSA-N acetyl-CoA Chemical compound O[C@@H]1[C@H](OP(O)(O)=O)[C@@H](COP(O)(=O)OP(O)(=O)OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCSC(=O)C)O[C@H]1N1C2=NC=NC(N)=C2N=C1 ZSLZBFCDCINBPY-ZSJPKINUSA-N 0.000 description 2
• 230000002411 adverse Effects 0.000 description 2
• 208000026935 allergic disease Diseases 0.000 description 2
• 108091008324 binding proteins Proteins 0.000 description 2
• 230000036770 blood supply Effects 0.000 description 2
• 210000001043 capillary endothelial cell Anatomy 0.000 description 2
• 150000001722 carbon compounds Chemical class 0.000 description 2
• 230000003197 catalytic effect Effects 0.000 description 2
• 230000035605 chemotaxis Effects 0.000 description 2
• HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
• OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 2
• 210000000349 chromosome Anatomy 0.000 description 2
• 201000010989 colorectal carcinoma Diseases 0.000 description 2
• 210000004351 coronary vessel Anatomy 0.000 description 2
• 231100000433 cytotoxic Toxicity 0.000 description 2
• 230000001472 cytotoxic effect Effects 0.000 description 2
• 235000011180 diphosphates Nutrition 0.000 description 2
• 108010067015 diphosphoinositol polyphosphate phosphohydrolase Proteins 0.000 description 2
• 230000012202 endocytosis Effects 0.000 description 2
• 208000023965 endometrium neoplasm Diseases 0.000 description 2
• 210000003038 endothelium Anatomy 0.000 description 2
• 210000003989 endothelium vascular Anatomy 0.000 description 2
• 208000037828 epithelial carcinoma Diseases 0.000 description 2
• 208000024519 eye neoplasm Diseases 0.000 description 2
• 210000002458 fetal heart Anatomy 0.000 description 2
• 229940126864 fibroblast growth factor Drugs 0.000 description 2
• 206010017758 gastric cancer Diseases 0.000 description 2
• 230000002068 genetic effect Effects 0.000 description 2
• 239000003862 glucocorticoid Substances 0.000 description 2
• XHMJOUIAFHJHBW-VFUOTHLCSA-N glucosamine 6-phosphate Chemical compound N[C@H]1[C@H](O)O[C@H](COP(O)(O)=O)[C@H](O)[C@@H]1O XHMJOUIAFHJHBW-VFUOTHLCSA-N 0.000 description 2
• 239000008103 glucose Substances 0.000 description 2
• ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 2
• 235000004554 glutamine Nutrition 0.000 description 2
• 229960002743 glutamine Drugs 0.000 description 2
• 238000006206 glycosylation reaction Methods 0.000 description 2
• 102000009543 guanyl-nucleotide exchange factor activity proteins Human genes 0.000 description 2
• 206010073071 hepatocellular carcinoma Diseases 0.000 description 2
• 230000009610 hypersensitivity Effects 0.000 description 2
• 238000011065 in-situ storage Methods 0.000 description 2
• 208000027866 inflammatory disease Diseases 0.000 description 2
• 230000002757 inflammatory effect Effects 0.000 description 2
• 201000003159 intraductal papilloma Diseases 0.000 description 2
• WZNJWVWKTVETCG-UHFFFAOYSA-N kojic acid Natural products OC(=O)C(N)CN1C=CC(=O)C(O)=C1 WZNJWVWKTVETCG-UHFFFAOYSA-N 0.000 description 2
• AEMOLEFTQBMNLQ-CLQWQSTFSA-N l-iduronic acid Chemical compound O[C@H]1O[C@H](C(O)=O)[C@H](O)[C@@H](O)[C@@H]1O AEMOLEFTQBMNLQ-CLQWQSTFSA-N 0.000 description 2
• 208000032839 leukemia Diseases 0.000 description 2
• 210000000265 leukocyte Anatomy 0.000 description 2
• 150000002632 lipids Chemical class 0.000 description 2
• 230000033001 locomotion Effects 0.000 description 2
• 201000005249 lung adenocarcinoma Diseases 0.000 description 2
• 201000005296 lung carcinoma Diseases 0.000 description 2
• 201000005243 lung squamous cell carcinoma Diseases 0.000 description 2
• 210000001165 lymph node Anatomy 0.000 description 2
• 210000004698 lymphocyte Anatomy 0.000 description 2
• 208000002780 macular degeneration Diseases 0.000 description 2
• 230000036210 malignancy Effects 0.000 description 2
• 208000015486 malignant pancreatic neoplasm Diseases 0.000 description 2
• 239000011159 matrix material Substances 0.000 description 2
• 230000001404 mediated effect Effects 0.000 description 2
• 208000023356 medullary thyroid gland carcinoma Diseases 0.000 description 2
• 210000004379 membrane Anatomy 0.000 description 2
• 238000000520 microinjection Methods 0.000 description 2
• 229950002289 mimosine Drugs 0.000 description 2
• 210000003470 mitochondria Anatomy 0.000 description 2
• 230000002438 mitochondrial effect Effects 0.000 description 2
• 108010046778 molybdenum cofactor Proteins 0.000 description 2
• HPEUEJRPDGMIMY-IFQPEPLCSA-N molybdopterin Chemical compound O([C@H]1N2)[C@H](COP(O)(O)=O)C(S)=C(S)[C@@H]1NC1=C2N=C(N)NC1=O HPEUEJRPDGMIMY-IFQPEPLCSA-N 0.000 description 2
• 230000003505 mutagenic effect Effects 0.000 description 2
• 230000035772 mutation Effects 0.000 description 2
• 201000003142 neovascular glaucoma Diseases 0.000 description 2
• 210000004498 neuroglial cell Anatomy 0.000 description 2
• 210000000440 neutrophil Anatomy 0.000 description 2
• 210000003101 oviduct Anatomy 0.000 description 2
• 230000003647 oxidation Effects 0.000 description 2
• 108010068338 p38 Mitogen-Activated Protein Kinases Proteins 0.000 description 2
• 229960001592 paclitaxel Drugs 0.000 description 2
• 210000002741 palatine tonsil Anatomy 0.000 description 2
• 201000002528 pancreatic cancer Diseases 0.000 description 2
• 208000008443 pancreatic carcinoma Diseases 0.000 description 2
• 201000010198 papillary carcinoma Diseases 0.000 description 2
• 101150093826 par1 gene Proteins 0.000 description 2
• PHEDXBVPIONUQT-RGYGYFBISA-N phorbol 13-acetate 12-myristate Chemical compound C([C@]1(O)C(=O)C(C)=C[C@H]1[C@@]1(O)[C@H](C)[C@H]2OC(=O)CCCCCCCCCCCCC)C(CO)=C[C@H]1[C@H]1[C@]2(OC(C)=O)C1(C)C PHEDXBVPIONUQT-RGYGYFBISA-N 0.000 description 2
• 210000003635 pituitary gland Anatomy 0.000 description 2
• 230000004911 positive regulation of CREB transcription factor activity Effects 0.000 description 2
• 238000012545 processing Methods 0.000 description 2
• NGVDGCNFYWLIFO-UHFFFAOYSA-N pyridoxal 5'-phosphate Chemical compound CC1=NC=C(COP(O)(O)=O)C(C=O)=C1O NGVDGCNFYWLIFO-UHFFFAOYSA-N 0.000 description 2
• 235000007682 pyridoxal 5'-phosphate Nutrition 0.000 description 2
• 239000011589 pyridoxal 5'-phosphate Substances 0.000 description 2
• 108010014186 ras Proteins Proteins 0.000 description 2
• 102000016914 ras Proteins Human genes 0.000 description 2
• 230000008439 repair process Effects 0.000 description 2
• 210000002460 smooth muscle Anatomy 0.000 description 2
• 210000000278 spinal cord Anatomy 0.000 description 2
• 210000003594 spinal ganglia Anatomy 0.000 description 2
• 150000003432 sterols Chemical class 0.000 description 2
• VNOYUJKHFWYWIR-ITIYDSSPSA-N succinyl-CoA Chemical compound O[C@@H]1[C@H](OP(O)(O)=O)[C@@H](COP(O)(=O)OP(O)(=O)OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCSC(=O)CCC(O)=O)O[C@H]1N1C2=NC=NC(N)=C2N=C1 VNOYUJKHFWYWIR-ITIYDSSPSA-N 0.000 description 2
• 108060007951 sulfatase Proteins 0.000 description 2
• 208000024891 symptom Diseases 0.000 description 2
• RCINICONZNJXQF-MZXODVADSA-N taxol Chemical compound O([C@@H]1[C@@]2(C[C@@H](C(C)=C(C2(C)C)[C@H](C([C@]2(C)[C@@H](O)C[C@H]3OC[C@]3([C@H]21)OC(C)=O)=O)OC(=O)C)OC(=O)[C@H](O)[C@@H](NC(=O)C=1C=CC=CC=1)C=1C=CC=CC=1)O)C(=O)C1=CC=CC=C1 RCINICONZNJXQF-MZXODVADSA-N 0.000 description 2
• 201000003120 testicular cancer Diseases 0.000 description 2
• 238000012546 transfer Methods 0.000 description 2
• 239000001226 triphosphate Substances 0.000 description 2
• 235000011178 triphosphate Nutrition 0.000 description 2
• 230000005748 tumor development Effects 0.000 description 2
• 230000002792 vascular Effects 0.000 description 2
• 210000003462 vein Anatomy 0.000 description 2
• 230000035899 viability Effects 0.000 description 2
• 230000037314 wound repair Effects 0.000 description 2
• YYGNTYWPHWGJRM-UHFFFAOYSA-N (6E,10E,14E,18E)-2,6,10,15,19,23-hexamethyltetracosa-2,6,10,14,18,22-hexaene Chemical compound CC(C)=CCCC(C)=CCCC(C)=CCCC=C(C)CCC=C(C)CCC=C(C)C YYGNTYWPHWGJRM-UHFFFAOYSA-N 0.000 description 1
• PHIQHXFUZVPYII-ZCFIWIBFSA-N (R)-carnitine Chemical compound C[N+](C)(C)C[C@H](O)CC([O-])=O PHIQHXFUZVPYII-ZCFIWIBFSA-N 0.000 description 1
• DWAKNKKXGALPNW-BYPYZUCNSA-N (S)-1-pyrroline-5-carboxylic acid Chemical compound OC(=O)[C@@H]1CCC=N1 DWAKNKKXGALPNW-BYPYZUCNSA-N 0.000 description 1
• 101710124165 1-acyl-sn-glycerol-3-phosphate acyltransferase Proteins 0.000 description 1
• 102100025573 1-alkyl-2-acetylglycerophosphocholine esterase Human genes 0.000 description 1
• KKVYYGGCHJGEFJ-UHFFFAOYSA-N 1-n-(4-chlorophenyl)-6-methyl-5-n-[3-(7h-purin-6-yl)pyridin-2-yl]isoquinoline-1,5-diamine Chemical compound N=1C=CC2=C(NC=3C(=CC=CN=3)C=3C=4N=CNC=4N=CN=3)C(C)=CC=C2C=1NC1=CC=C(Cl)C=C1 KKVYYGGCHJGEFJ-UHFFFAOYSA-N 0.000 description 1
• 108010052341 1-phosphatidylinositol-4-phosphate 5-kinase Proteins 0.000 description 1
• 108010082310 2-hydroxyacid dehydrogenase Proteins 0.000 description 1
• 108010021680 2-oxoglutarate decarboxylase Proteins 0.000 description 1
• 108050003384 2-oxoglutarate dehydrogenase E1 component Proteins 0.000 description 1
• KPGXRSRHYNQIFN-UHFFFAOYSA-N 2-oxoglutaric acid Chemical compound OC(=O)CCC(=O)C(O)=O KPGXRSRHYNQIFN-UHFFFAOYSA-N 0.000 description 1
• 102000009478 3'5'-cyclic nucleotide phosphodiesterases Human genes 0.000 description 1
• 108050000390 3'5'-cyclic nucleotide phosphodiesterases Proteins 0.000 description 1
• 108700020831 3-Hydroxyacyl-CoA Dehydrogenase Proteins 0.000 description 1
• 102000009878 3-Hydroxysteroid Dehydrogenases Human genes 0.000 description 1
• KPULXFNPTWGJQH-UHFFFAOYSA-N 3-hydroxy-4-oxo-4-propan-2-yloxybutanoic acid Chemical compound CC(C)OC(=O)C(O)CC(O)=O KPULXFNPTWGJQH-UHFFFAOYSA-N 0.000 description 1
• DODQJNMQWMSYGS-QPLCGJKRSA-N 4-[(z)-1-[4-[2-(dimethylamino)ethoxy]phenyl]-1-phenylbut-1-en-2-yl]phenol Chemical compound C=1C=C(O)C=CC=1C(/CC)=C(C=1C=CC(OCCN(C)C)=CC=1)/C1=CC=CC=C1 DODQJNMQWMSYGS-QPLCGJKRSA-N 0.000 description 1
• FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 description 1
• 108010075604 5-Methyltetrahydrofolate-Homocysteine S-Methyltransferase Proteins 0.000 description 1
• 102000011848 5-Methyltetrahydrofolate-Homocysteine S-Methyltransferase Human genes 0.000 description 1
• ZUNFHPIYIPQTIE-RTMIPMGSSA-N 5-[2-(3-azidophenyl)ethyl-(tritritiomethyl)amino]-2-propan-2-yl-2-(3,4,5-trimethoxyphenyl)pentanenitrile;hydrochloride Chemical compound Cl.C=1C=CC(N=[N+]=[N-])=CC=1CCN(C([3H])([3H])[3H])CCCC(C#N)(C(C)C)C1=CC(OC)=C(OC)C(OC)=C1 ZUNFHPIYIPQTIE-RTMIPMGSSA-N 0.000 description 1
• 108010029731 6-phosphogluconolactonase Proteins 0.000 description 1
• 102100031126 6-phosphogluconolactonase Human genes 0.000 description 1
• 102100028505 6-pyruvoyl tetrahydrobiopterin synthase Human genes 0.000 description 1
• 108010045523 6-pyruvoyltetrahydropterin synthase Proteins 0.000 description 1
• CLGFIVUFZRGQRP-UHFFFAOYSA-N 7,8-dihydro-8-oxoguanine Chemical compound O=C1NC(N)=NC2=C1NC(=O)N2 CLGFIVUFZRGQRP-UHFFFAOYSA-N 0.000 description 1
• AQIVLFLYHYFRKU-VPENINKCSA-N 8-oxo-dGMP Chemical compound O=C1NC=2C(=O)NC(N)=NC=2N1[C@H]1C[C@H](O)[C@@H](COP(O)(O)=O)O1 AQIVLFLYHYFRKU-VPENINKCSA-N 0.000 description 1
• UBKVUFQGVWHZIR-UHFFFAOYSA-N 8-oxoguanine Chemical compound O=C1NC(N)=NC2=NC(=O)N=C21 UBKVUFQGVWHZIR-UHFFFAOYSA-N 0.000 description 1
• 108010049290 ADP Ribose Transferases Proteins 0.000 description 1
• 102000009062 ADP Ribose Transferases Human genes 0.000 description 1
• 108010071550 ATP-Dependent Proteases Proteins 0.000 description 1
• 102000007566 ATP-Dependent Proteases Human genes 0.000 description 1
• 102100033350 ATP-dependent translocase ABCB1 Human genes 0.000 description 1
• 108091006112 ATPases Proteins 0.000 description 1
• 102000011932 ATPases Associated with Diverse Cellular Activities Human genes 0.000 description 1
• 108010075752 ATPases Associated with Diverse Cellular Activities Proteins 0.000 description 1
• 102000007469 Actins Human genes 0.000 description 1
• 108010085238 Actins Proteins 0.000 description 1
• 102100021029 Activating signal cointegrator 1 complex subunit 3 Human genes 0.000 description 1
• 208000004804 Adenomatous Polyps Diseases 0.000 description 1
• 102000057290 Adenosine Triphosphatases Human genes 0.000 description 1
• 102100020925 Adenosylhomocysteinase Human genes 0.000 description 1
• 108020002202 Adenosylhomocysteinase Proteins 0.000 description 1
• 206010001497 Agitation Diseases 0.000 description 1
• 108010031025 Alanine Dehydrogenase Proteins 0.000 description 1
• 102000005369 Aldehyde Dehydrogenase Human genes 0.000 description 1
• 108020002663 Aldehyde Dehydrogenase Proteins 0.000 description 1
• 201000004384 Alopecia Diseases 0.000 description 1
• 108700023418 Amidases Proteins 0.000 description 1
• 108010028700 Amine Oxidase (Copper-Containing) Proteins 0.000 description 1
• 102100022014 Angiopoietin-1 receptor Human genes 0.000 description 1
• 201000003076 Angiosarcoma Diseases 0.000 description 1
• 108020000948 Antisense Oligonucleotides Proteins 0.000 description 1
• 101000807639 Arabidopsis thaliana Uridine/cytidine kinase UKL1, chloroplastic Proteins 0.000 description 1
• 241000370685 Arge Species 0.000 description 1
• 102000004452 Arginase Human genes 0.000 description 1
• 108700024123 Arginases Proteins 0.000 description 1
• 102000000632 Aromatic amino acid hydroxylases Human genes 0.000 description 1
• 108050008079 Aromatic amino acid hydroxylases Proteins 0.000 description 1
• 102000006809 Arylamine N-Acetyltransferase Human genes 0.000 description 1
• 108020005224 Arylamine N-acetyltransferase Proteins 0.000 description 1
• 108010008184 Aryldialkylphosphatase Proteins 0.000 description 1
• 102000006996 Aryldialkylphosphatase Human genes 0.000 description 1
• 102000009133 Arylsulfatases Human genes 0.000 description 1
• 108010024976 Asparaginase Proteins 0.000 description 1
• 108010070255 Aspartate-ammonia ligase Proteins 0.000 description 1
• 108010017640 Aspartic Acid Proteases Proteins 0.000 description 1
• 102000004580 Aspartic Acid Proteases Human genes 0.000 description 1
• 206010003571 Astrocytoma Diseases 0.000 description 1
• 206010061692 Benign muscle neoplasm Diseases 0.000 description 1
• DWRXFEITVBNRMK-UHFFFAOYSA-N Beta-D-1-Arabinofuranosylthymine Natural products O=C1NC(=O)C(C)=CN1C1C(O)C(O)C(CO)O1 DWRXFEITVBNRMK-UHFFFAOYSA-N 0.000 description 1
• 102000011802 Beta-ketoacyl synthases Human genes 0.000 description 1
• 108050002233 Beta-ketoacyl synthases Proteins 0.000 description 1
• 108050003866 Bifunctional ligase/repressor BirA Proteins 0.000 description 1
• 102100027950 Bile acid-CoA:amino acid N-acyltransferase Human genes 0.000 description 1
• 108030000726 Bile acid-CoA:amino acid N-acyltransferases Proteins 0.000 description 1
• 108010017500 Biliverdin reductase Proteins 0.000 description 1
• 102100033743 Biotin-[acetyl-CoA-carboxylase] ligase Human genes 0.000 description 1
• 108010029692 Bisphosphoglycerate mutase Proteins 0.000 description 1
• 206010005003 Bladder cancer Diseases 0.000 description 1
• 102100028237 Breast cancer anti-estrogen resistance protein 1 Human genes 0.000 description 1
• 108050007340 Breast cancer anti-estrogen resistance protein 1 Proteins 0.000 description 1
• 208000007690 Brenner tumor Diseases 0.000 description 1
• 206010073258 Brenner tumour Diseases 0.000 description 1
• 208000003170 Bronchiolo-Alveolar Adenocarcinoma Diseases 0.000 description 1
• 101710082260 C-4 methylsterol oxidase Proteins 0.000 description 1
• 102000010101 CDP-alcohol phosphatidyltransferases Human genes 0.000 description 1
• 108050001760 CDP-alcohol phosphatidyltransferases Proteins 0.000 description 1
• OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
• 102000003846 Carbonic anhydrases Human genes 0.000 description 1
• 108090000209 Carbonic anhydrases Proteins 0.000 description 1
• 108010051152 Carboxylesterase Proteins 0.000 description 1
• 102000013392 Carboxylesterase Human genes 0.000 description 1
• 206010007559 Cardiac failure congestive Diseases 0.000 description 1
• 108010018424 Carnitine O-palmitoyltransferase Proteins 0.000 description 1
• 102000002666 Carnitine O-palmitoyltransferase Human genes 0.000 description 1
• 108010078791 Carrier Proteins Proteins 0.000 description 1
• 208000002177 Cataract Diseases 0.000 description 1
• 206010008342 Cervix carcinoma Diseases 0.000 description 1
• 102100029172 Choline-phosphate cytidylyltransferase A Human genes 0.000 description 1
• 101710100763 Choline-phosphate cytidylyltransferase A Proteins 0.000 description 1
• 208000005243 Chondrosarcoma Diseases 0.000 description 1
• 201000009047 Chordoma Diseases 0.000 description 1
• 208000005590 Choroidal Neovascularization Diseases 0.000 description 1
• 206010060823 Choroidal neovascularisation Diseases 0.000 description 1
• PHEDXBVPIONUQT-UHFFFAOYSA-N Cocarcinogen A1 Natural products CCCCCCCCCCCCCC(=O)OC1C(C)C2(O)C3C=C(C)C(=O)C3(O)CC(CO)=CC2C2C1(OC(C)=O)C2(C)C PHEDXBVPIONUQT-UHFFFAOYSA-N 0.000 description 1
• 102000029816 Collagenase Human genes 0.000 description 1
• 108060005980 Collagenase Proteins 0.000 description 1
• 102000008954 Copper amine oxidases Human genes 0.000 description 1
• 208000009798 Craniopharyngioma Diseases 0.000 description 1
• 102100025287 Cytochrome b Human genes 0.000 description 1
• 108010052832 Cytochromes Proteins 0.000 description 1
• 102000018832 Cytochromes Human genes 0.000 description 1
• 108010075028 Cytochromes b Proteins 0.000 description 1
• FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
• 108010003989 D-amino-acid oxidase Proteins 0.000 description 1
• LHQIJBMDNUYRAM-AWFVSMACSA-N D-erythro-biopterin Chemical compound N1=C(N)NC(=O)C2=NC([C@H](O)[C@H](O)C)=CN=C21 LHQIJBMDNUYRAM-AWFVSMACSA-N 0.000 description 1
• 108010033333 DEAD-box RNA Helicases Proteins 0.000 description 1
• 102000007120 DEAD-box RNA Helicases Human genes 0.000 description 1
• 102000040253 DIPP family Human genes 0.000 description 1
• 108091074616 DIPP family Proteins 0.000 description 1
• 102000052510 DNA-Binding Proteins Human genes 0.000 description 1
• 102000016923 DNA-Cytosine Methylases Human genes 0.000 description 1
• 108010014312 DNA-Cytosine Methylases Proteins 0.000 description 1
• 101710096438 DNA-binding protein Proteins 0.000 description 1
• 208000002249 Diabetes Complications Diseases 0.000 description 1
• 206010012655 Diabetic complications Diseases 0.000 description 1
• 102000028526 Dihydrolipoamide Dehydrogenase Human genes 0.000 description 1
• 108010028127 Dihydrolipoamide Dehydrogenase Proteins 0.000 description 1
• 102100031920 Dihydrolipoyllysine-residue succinyltransferase component of 2-oxoglutarate dehydrogenase complex, mitochondrial Human genes 0.000 description 1
• 108091000126 Dihydroorotase Proteins 0.000 description 1
• 108010006731 Dimethylallyltranstransferase Proteins 0.000 description 1
• 102000005454 Dimethylallyltranstransferase Human genes 0.000 description 1
• 102000003850 Dipeptidase 1 Human genes 0.000 description 1
• 108090000204 Dipeptidase 1 Proteins 0.000 description 1
• 101000601610 Drosophila melanogaster Heparan sulfate N-sulfotransferase Proteins 0.000 description 1
• 108030004793 Dual-specificity kinases Proteins 0.000 description 1
• 206010058314 Dysplasia Diseases 0.000 description 1
• 102000036530 EDG receptors Human genes 0.000 description 1
• 108091007263 EDG receptors Proteins 0.000 description 1
• 102000001301 EGF receptor Human genes 0.000 description 1
• 108060006698 EGF receptor Proteins 0.000 description 1
• 208000009701 Embryo Loss Diseases 0.000 description 1
• 206010014733 Endometrial cancer Diseases 0.000 description 1
• 206010014759 Endometrial neoplasm Diseases 0.000 description 1
• 206010014967 Ependymoma Diseases 0.000 description 1
• 101800003838 Epidermal growth factor Proteins 0.000 description 1
• 208000031637 Erythroblastic Acute Leukemia Diseases 0.000 description 1
• 208000036566 Erythroleukaemia Diseases 0.000 description 1
• 208000000461 Esophageal Neoplasms Diseases 0.000 description 1
• 208000006168 Ewing Sarcoma Diseases 0.000 description 1
• 108010007457 Extracellular Signal-Regulated MAP Kinases Proteins 0.000 description 1
• 102000007665 Extracellular Signal-Regulated MAP Kinases Human genes 0.000 description 1
• 102000002779 FAD-dependent glycerol-3-phosphate dehydrogenase Human genes 0.000 description 1
• 108020000296 FAD-dependent glycerol-3-phosphate dehydrogenase Proteins 0.000 description 1
• 101710116650 FAD-dependent monooxygenase Proteins 0.000 description 1
• YPZRHBJKEMOYQH-UYBVJOGSSA-N FADH2 Chemical compound C1=NC2=C(N)N=CN=C2N1[C@@H]([C@H](O)[C@@H]1O)O[C@@H]1COP(O)(=O)OP(O)(=O)OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C(NC(=O)NC2=O)=C2NC2=C1C=C(C)C(C)=C2 YPZRHBJKEMOYQH-UYBVJOGSSA-N 0.000 description 1
• 102100038665 FGGY carbohydrate kinase domain-containing protein Human genes 0.000 description 1
• 102000008956 FMN-dependent dehydrogenases Human genes 0.000 description 1
• 108050000913 FMN-dependent dehydrogenases Proteins 0.000 description 1
• 108010022535 Farnesyl-Diphosphate Farnesyltransferase Proteins 0.000 description 1
• 102000009114 Fatty acid desaturases Human genes 0.000 description 1
• 108010087894 Fatty acid desaturases Proteins 0.000 description 1
• 208000007659 Fibroadenoma Diseases 0.000 description 1
• 201000008808 Fibrosarcoma Diseases 0.000 description 1
• 206010016654 Fibrosis Diseases 0.000 description 1
• 102100035427 Forkhead box protein O1 Human genes 0.000 description 1
• 102100025413 Formyltetrahydrofolate synthetase Human genes 0.000 description 1
• 229930091371 Fructose Natural products 0.000 description 1
• RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
• 239000005715 Fructose Substances 0.000 description 1
• 102000001390 Fructose-Bisphosphate Aldolase Human genes 0.000 description 1
• 108010068561 Fructose-Bisphosphate Aldolase Proteins 0.000 description 1
• 108010013942 GMP Reductase Proteins 0.000 description 1
• 102000017179 GMP reductase Human genes 0.000 description 1
• 108010023555 GTP Cyclohydrolase Proteins 0.000 description 1
• 102000013446 GTP Phosphohydrolases Human genes 0.000 description 1
• 102100027346 GTP cyclohydrolase 1 Human genes 0.000 description 1
• 102100029974 GTPase HRas Human genes 0.000 description 1
• 108091006109 GTPases Proteins 0.000 description 1
• 108020004206 Gamma-glutamyltransferase Proteins 0.000 description 1
• 108010066605 Geranylgeranyl-Diphosphate Geranylgeranyltransferase Proteins 0.000 description 1
• 208000021309 Germ cell tumor Diseases 0.000 description 1
• 108010070600 Glucose-6-phosphate isomerase Proteins 0.000 description 1
• 102000005731 Glucose-6-phosphate isomerase Human genes 0.000 description 1
• 108010018962 Glucosephosphate Dehydrogenase Proteins 0.000 description 1
• 101710122170 Glutamate dehydrogenase 1 Proteins 0.000 description 1
• 102100034009 Glutamate dehydrogenase 1, mitochondrial Human genes 0.000 description 1
• WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
• 102000006587 Glutathione peroxidase Human genes 0.000 description 1
• 108700016172 Glutathione peroxidases Proteins 0.000 description 1
• 108010041921 Glycerolphosphate Dehydrogenase Proteins 0.000 description 1
• 102000000587 Glycerolphosphate Dehydrogenase Human genes 0.000 description 1
• 108010043428 Glycine hydroxymethyltransferase Proteins 0.000 description 1
• 229920002306 Glycocalyx Polymers 0.000 description 1
• 229920002527 Glycogen Polymers 0.000 description 1
• 229930186217 Glycolipid Natural products 0.000 description 1
• 102000003886 Glycoproteins Human genes 0.000 description 1
• 108090000288 Glycoproteins Proteins 0.000 description 1
• 108010016306 Glycylpeptide N-tetradecanoyltransferase Proteins 0.000 description 1
• 102100028085 Glycylpeptide N-tetradecanoyltransferase 1 Human genes 0.000 description 1
• 229930189936 Glyoxalase Natural products 0.000 description 1
• 102100039620 Granulocyte-macrophage colony-stimulating factor Human genes 0.000 description 1
• 108010078321 Guanylate Cyclase Proteins 0.000 description 1
• 102000014348 Haloacid dehalogenase-like hydrolases Human genes 0.000 description 1
• 108050003363 Haloacid dehalogenase-like hydrolases Proteins 0.000 description 1
• 206010019280 Heart failures Diseases 0.000 description 1
• 101710180472 Helicase-like transcription factor Proteins 0.000 description 1
• 101710090680 Hemoglobinase Proteins 0.000 description 1
• 108010022901 Heparin Lyase Proteins 0.000 description 1
• 241000545744 Hirudinea Species 0.000 description 1
• 102000030789 Histidine Ammonia-Lyase Human genes 0.000 description 1
• 108700006308 Histidine ammonia-lyases Proteins 0.000 description 1
• 108090000353 Histone deacetylase Proteins 0.000 description 1
• 102000003964 Histone deacetylase Human genes 0.000 description 1
• 101000866618 Homo sapiens 3-beta-hydroxysteroid-Delta(8),Delta(7)-isomerase Proteins 0.000 description 1
• 101000600756 Homo sapiens 3-phosphoinositide-dependent protein kinase 1 Proteins 0.000 description 1
• 101000784211 Homo sapiens Activating signal cointegrator 1 complex subunit 3 Proteins 0.000 description 1
• 101000753291 Homo sapiens Angiopoietin-1 receptor Proteins 0.000 description 1
• 101000762370 Homo sapiens BMP-2-inducible protein kinase Proteins 0.000 description 1
• 101000992065 Homo sapiens Dihydrolipoyllysine-residue succinyltransferase component of 2-oxoglutarate dehydrogenase complex, mitochondrial Proteins 0.000 description 1
• 101001031630 Homo sapiens FGGY carbohydrate kinase domain-containing protein Proteins 0.000 description 1
• 101000877727 Homo sapiens Forkhead box protein O1 Proteins 0.000 description 1
• 101000584633 Homo sapiens GTPase HRas Proteins 0.000 description 1
• 101000746373 Homo sapiens Granulocyte-macrophage colony-stimulating factor Proteins 0.000 description 1
• 101001027628 Homo sapiens Kinesin-like protein KIF21A Proteins 0.000 description 1
• 101000605743 Homo sapiens Kinesin-like protein KIF23 Proteins 0.000 description 1
• 101000950687 Homo sapiens Mitogen-activated protein kinase 7 Proteins 0.000 description 1
• 101000950669 Homo sapiens Mitogen-activated protein kinase 9 Proteins 0.000 description 1
• 101000901659 Homo sapiens Myotonin-protein kinase Proteins 0.000 description 1
• 101000603202 Homo sapiens Nicotinamide N-methyltransferase Proteins 0.000 description 1
• 101100350243 Homo sapiens OGDHL gene Proteins 0.000 description 1
• 101100191012 Homo sapiens PON3 gene Proteins 0.000 description 1
• 101001123678 Homo sapiens Phenylethanolamine N-methyltransferase Proteins 0.000 description 1
• 101001095266 Homo sapiens Prolyl endopeptidase Proteins 0.000 description 1
• 101001098989 Homo sapiens Propionyl-CoA carboxylase alpha chain, mitochondrial Proteins 0.000 description 1
• 101001100204 Homo sapiens Ras-related protein Rab-40A-like Proteins 0.000 description 1
• 101000661819 Homo sapiens Serine/threonine-protein kinase 17B Proteins 0.000 description 1
• 101001059454 Homo sapiens Serine/threonine-protein kinase MARK2 Proteins 0.000 description 1
• 101001117146 Homo sapiens [Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 1, mitochondrial Proteins 0.000 description 1
• 101000919269 Homo sapiens cAMP-responsive element modulator Proteins 0.000 description 1
• 108010003272 Hyaluronate lyase Proteins 0.000 description 1
• 102000001974 Hyaluronidases Human genes 0.000 description 1
• 108010056651 Hydroxymethylbilane synthase Proteins 0.000 description 1
• 206010020852 Hypertonia Diseases 0.000 description 1
• 206010021143 Hypoxia Diseases 0.000 description 1
• 102000038455 IGF Type 1 Receptor Human genes 0.000 description 1
• 108010031794 IGF Type 1 Receptor Proteins 0.000 description 1
• 108010087227 IMP Dehydrogenase Proteins 0.000 description 1
• 102000006674 IMP dehydrogenase Human genes 0.000 description 1
• 208000026350 Inborn Genetic disease Diseases 0.000 description 1
• 102100033180 Indolethylamine N-methyltransferase Human genes 0.000 description 1
• 101710115499 Indolethylamine N-methyltransferase Proteins 0.000 description 1
• 102100021496 Insulin-degrading enzyme Human genes 0.000 description 1
• 108090000828 Insulysin Proteins 0.000 description 1
• 108010002386 Interleukin-3 Proteins 0.000 description 1
• 102000000646 Interleukin-3 Human genes 0.000 description 1
• 108090001007 Interleukin-8 Proteins 0.000 description 1
• 208000037396 Intraductal Noninfiltrating Carcinoma Diseases 0.000 description 1
• 206010073094 Intraductal proliferative breast lesion Diseases 0.000 description 1
• 206010065630 Iris neovascularisation Diseases 0.000 description 1
• 108010044467 Isoenzymes Proteins 0.000 description 1
• 102100037688 Kinesin-like protein KIF21A Human genes 0.000 description 1
• 102100038406 Kinesin-like protein KIF23 Human genes 0.000 description 1
• 101710134365 Kinesin-like protein KIF2A Proteins 0.000 description 1
• 102100023424 Kinesin-like protein KIF2C Human genes 0.000 description 1
• 101710134369 Kinesin-like protein KIF2C Proteins 0.000 description 1
• 208000000675 Krukenberg Tumor Diseases 0.000 description 1
• CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
• LHQIJBMDNUYRAM-UHFFFAOYSA-N L-erythro-Biopterin Natural products N1=C(N)NC(=O)C2=NC(C(O)C(O)C)=CN=C21 LHQIJBMDNUYRAM-UHFFFAOYSA-N 0.000 description 1
• WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 1
• 102000003855 L-lactate dehydrogenase Human genes 0.000 description 1
• 108700023483 L-lactate dehydrogenases Proteins 0.000 description 1
• FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 1
• COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 1
• JVTAAEKCZFNVCJ-UHFFFAOYSA-M Lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 description 1
• 208000018142 Leiomyosarcoma Diseases 0.000 description 1
• 101710180643 Leishmanolysin Proteins 0.000 description 1
• 101001110310 Lentilactobacillus kefiri NADP-dependent (R)-specific alcohol dehydrogenase Proteins 0.000 description 1
• 108010013563 Lipoprotein Lipase Proteins 0.000 description 1
• 102100022119 Lipoprotein lipase Human genes 0.000 description 1
• 102000003820 Lipoxygenases Human genes 0.000 description 1
• 108090000128 Lipoxygenases Proteins 0.000 description 1
• 206010073099 Lobular breast carcinoma in situ Diseases 0.000 description 1
• 108020002496 Lysophospholipase Proteins 0.000 description 1
• 101710097496 Lysophospholipid acyltransferase Proteins 0.000 description 1
• 102000001291 MAP Kinase Kinase Kinase Human genes 0.000 description 1
• 108010048043 Macrophage Migration-Inhibitory Factors Proteins 0.000 description 1
• 102100037791 Macrophage migration inhibitory factor Human genes 0.000 description 1
• 108010026217 Malate Dehydrogenase Proteins 0.000 description 1
• 102000013460 Malate Dehydrogenase Human genes 0.000 description 1
• 241000124008 Mammalia Species 0.000 description 1
• 108091022912 Mannose-6-Phosphate Isomerase Proteins 0.000 description 1
• 101100238641 Medicago sativa MSK-2 gene Proteins 0.000 description 1
• 208000000172 Medulloblastoma Diseases 0.000 description 1
• 108010047230 Member 1 Subfamily B ATP Binding Cassette Transporter Proteins 0.000 description 1
• 102000018697 Membrane Proteins Human genes 0.000 description 1
• 108010052285 Membrane Proteins Proteins 0.000 description 1
• 102000003939 Membrane transport proteins Human genes 0.000 description 1
• 108090000301 Membrane transport proteins Proteins 0.000 description 1
• 208000036626 Mental retardation Diseases 0.000 description 1
• 206010027406 Mesothelioma Diseases 0.000 description 1
• 206010027462 Metastases to ovary Diseases 0.000 description 1
• 108010010685 Methenyltetrahydrofolate cyclohydrolase Proteins 0.000 description 1
• 108010007784 Methionine adenosyltransferase Proteins 0.000 description 1
• 102100025825 Methylated-DNA-protein-cysteine methyltransferase Human genes 0.000 description 1
• 101710104913 Methylated-DNA-protein-cysteine methyltransferase Proteins 0.000 description 1
• 101710142850 Methylsterol monooxygenase 1 Proteins 0.000 description 1
• 102100021091 Methylsterol monooxygenase 1 Human genes 0.000 description 1
• 108020005196 Mitochondrial DNA Proteins 0.000 description 1
• 108090000744 Mitogen-Activated Protein Kinase Kinases Proteins 0.000 description 1
• 102000004232 Mitogen-Activated Protein Kinase Kinases Human genes 0.000 description 1
• 102100037809 Mitogen-activated protein kinase 9 Human genes 0.000 description 1
• 102100033116 Mitogen-activated protein kinase kinase kinase 20 Human genes 0.000 description 1
• 108030005453 Mitogen-activated protein kinase kinase kinases Proteins 0.000 description 1
• 102000007474 Multiprotein Complexes Human genes 0.000 description 1
• 108010085220 Multiprotein Complexes Proteins 0.000 description 1
• 101000762365 Mus musculus Bone morphogenetic protein 2 Proteins 0.000 description 1
• 101100381978 Mus musculus Braf gene Proteins 0.000 description 1
• 101000654471 Mus musculus NAD-dependent protein deacetylase sirtuin-1 Proteins 0.000 description 1
• 241000699670 Mus sp. Species 0.000 description 1
• 206010028400 Mutagenic effect Diseases 0.000 description 1
• 101710135898 Myc proto-oncogene protein Proteins 0.000 description 1
• 102100038895 Myc proto-oncogene protein Human genes 0.000 description 1
• 201000004458 Myoma Diseases 0.000 description 1
• PRQROPMIIGLWRP-UHFFFAOYSA-N N-formyl-methionyl-leucyl-phenylalanin Chemical compound CSCCC(NC=O)C(=O)NC(CC(C)C)C(=O)NC(C(O)=O)CC1=CC=CC=C1 PRQROPMIIGLWRP-UHFFFAOYSA-N 0.000 description 1
• 101710138296 NADPH oxidoreductase Proteins 0.000 description 1
• 108010057466 NF-kappa B Proteins 0.000 description 1
• 102000003945 NF-kappa B Human genes 0.000 description 1
• 101150097297 Nedd4 gene Proteins 0.000 description 1
• 206010029098 Neoplasm skin Diseases 0.000 description 1
• 206010029260 Neuroblastoma Diseases 0.000 description 1
• 108090000812 Neurolysin Proteins 0.000 description 1
• 102100023072 Neurolysin, mitochondrial Human genes 0.000 description 1
• 102100038951 Nicotinamide N-methyltransferase Human genes 0.000 description 1
• 102000004459 Nitroreductase Human genes 0.000 description 1
• 208000015914 Non-Hodgkin lymphomas Diseases 0.000 description 1
• 102000007399 Nuclear hormone receptor Human genes 0.000 description 1
• 108020005497 Nuclear hormone receptor Proteins 0.000 description 1
• 102000013901 Nucleoside diphosphate kinase Human genes 0.000 description 1
• 102100021969 Nucleotide pyrophosphatase Human genes 0.000 description 1
• 102000003832 Nucleotidyltransferases Human genes 0.000 description 1
• 108090000119 Nucleotidyltransferases Proteins 0.000 description 1
• 101710128228 O-methyltransferase Proteins 0.000 description 1
• 206010030155 Oesophageal carcinoma Diseases 0.000 description 1
• 102000043276 Oncogene Human genes 0.000 description 1
• 101710146878 Ornithine carbamoyltransferase, catabolic Proteins 0.000 description 1
• 101710198224 Ornithine carbamoyltransferase, mitochondrial Proteins 0.000 description 1
• 101710113020 Ornithine transcarbamylase, mitochondrial Proteins 0.000 description 1
• 102100028200 Ornithine transcarbamylase, mitochondrial Human genes 0.000 description 1
• 208000010191 Osteitis Deformans Diseases 0.000 description 1
• 101710160107 Outer membrane protein A Proteins 0.000 description 1
• 229940116355 PI3 kinase inhibitor Drugs 0.000 description 1
• 239000012828 PI3K inhibitor Substances 0.000 description 1
• 229910019142 PO4 Inorganic materials 0.000 description 1
• 208000027868 Paget disease Diseases 0.000 description 1
• 108700023158 Phenylalanine ammonia-lyases Proteins 0.000 description 1
• 102100028917 Phenylethanolamine N-methyltransferase Human genes 0.000 description 1
• 102000014418 Phosphatidylinositol-4-phosphate 5-kinases Human genes 0.000 description 1
• 108010010677 Phosphodiesterase I Proteins 0.000 description 1
• 101710138230 Phosphoglucomutase/phosphomannomutase Proteins 0.000 description 1
• 102000011755 Phosphoglycerate Kinase Human genes 0.000 description 1
• 102000011025 Phosphoglycerate Mutase Human genes 0.000 description 1
• 108010058864 Phospholipases A2 Proteins 0.000 description 1
• 102100035362 Phosphomannomutase 2 Human genes 0.000 description 1
• 108010022181 Phosphopyruvate Hydratase Proteins 0.000 description 1
• 102000012288 Phosphopyruvate Hydratase Human genes 0.000 description 1
• 102100027330 Phosphoribosylaminoimidazole carboxylase Human genes 0.000 description 1
• 108090001050 Phosphoric Diester Hydrolases Proteins 0.000 description 1
• 241001440127 Phyllodes Species 0.000 description 1
• 208000007641 Pinealoma Diseases 0.000 description 1
• 108010001014 Plasminogen Activators Proteins 0.000 description 1
• 102000001938 Plasminogen Activators Human genes 0.000 description 1
• FKUYMLZIRPABFK-UHFFFAOYSA-N Plastoquinone 9 Natural products CC(C)=CCCC(C)=CCCC(C)=CCCC(C)=CCCC(C)=CCCC(C)=CCCC(C)=CCCC(C)=CCCC(C)=CCC1=CC(=O)C(C)=C(C)C1=O FKUYMLZIRPABFK-UHFFFAOYSA-N 0.000 description 1
• 206010035610 Pleural Neoplasms Diseases 0.000 description 1
• 208000002664 Pleural Solitary Fibrous Tumor Diseases 0.000 description 1
• 102000012338 Poly(ADP-ribose) Polymerases Human genes 0.000 description 1
• 108010061844 Poly(ADP-ribose) Polymerases Proteins 0.000 description 1
• 229920000776 Poly(Adenosine diphosphate-ribose) polymerase Polymers 0.000 description 1
• 229920000388 Polyphosphate Polymers 0.000 description 1
• 102100034391 Porphobilinogen deaminase Human genes 0.000 description 1
• 108010072970 Porphobilinogen synthase Proteins 0.000 description 1
• 101710098940 Pro-epidermal growth factor Proteins 0.000 description 1
• 108010064622 Procollagen N-Endopeptidase Proteins 0.000 description 1
• 102000015339 Procollagen N-endopeptidase Human genes 0.000 description 1
• 102000056251 Prolyl Oligopeptidases Human genes 0.000 description 1
• 102100039022 Propionyl-CoA carboxylase alpha chain, mitochondrial Human genes 0.000 description 1
• 102100032258 Prostaglandin reductase 1 Human genes 0.000 description 1
• 108090000459 Prostaglandin-endoperoxide synthases Proteins 0.000 description 1
• 102000004005 Prostaglandin-endoperoxide synthases Human genes 0.000 description 1
• 101710180316 Protease 2 Proteins 0.000 description 1
• 108010029485 Protein Isoforms Proteins 0.000 description 1
• 102000001708 Protein Isoforms Human genes 0.000 description 1
• 108091008611 Protein Kinase B Proteins 0.000 description 1
• 108010001267 Protein Subunits Proteins 0.000 description 1
• 102000002067 Protein Subunits Human genes 0.000 description 1
• 102100027584 Protein c-Fos Human genes 0.000 description 1
• 102000004022 Protein-Tyrosine Kinases Human genes 0.000 description 1
• 108090000412 Protein-Tyrosine Kinases Proteins 0.000 description 1
• 102000007568 Proto-Oncogene Proteins c-fos Human genes 0.000 description 1
• 108010071563 Proto-Oncogene Proteins c-fos Proteins 0.000 description 1
• 108010054917 Pyrimidine Phosphorylases Proteins 0.000 description 1
• 102000001853 Pyrimidine Phosphorylases Human genes 0.000 description 1
• 102000009609 Pyrophosphatases Human genes 0.000 description 1
• 108010009413 Pyrophosphatases Proteins 0.000 description 1
• 108020005115 Pyruvate Kinase Proteins 0.000 description 1
• 102000013009 Pyruvate Kinase Human genes 0.000 description 1
• 102100033810 RAC-alpha serine/threonine-protein kinase Human genes 0.000 description 1
• 102100038416 Ras-related protein Rab-40A-like Human genes 0.000 description 1
• 101100108100 Rattus norvegicus Acy1a gene Proteins 0.000 description 1
• 101100108101 Rattus norvegicus Acy1b gene Proteins 0.000 description 1
• 208000015634 Rectal Neoplasms Diseases 0.000 description 1
• 208000006265 Renal cell carcinoma Diseases 0.000 description 1
• 108050002653 Retinoblastoma protein Proteins 0.000 description 1
• AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 1
• 108010083644 Ribonucleases Proteins 0.000 description 1
• 102000006382 Ribonucleases Human genes 0.000 description 1
• 108020000772 Ribose-Phosphate Pyrophosphokinase Proteins 0.000 description 1
• 102000000439 Ribose-phosphate pyrophosphokinase Human genes 0.000 description 1
• 102000015882 Ribosomal RNA adenine dimethylases Human genes 0.000 description 1
• 108050004225 Ribosomal RNA adenine dimethylases Proteins 0.000 description 1
• 101000744001 Ruminococcus gnavus (strain ATCC 29149 / VPI C7-9) 3beta-hydroxysteroid dehydrogenase Proteins 0.000 description 1
• MEFKEPWMEQBLKI-AIRLBKTGSA-N S-adenosyl-L-methioninate Chemical compound O[C@@H]1[C@H](O)[C@@H](C[S+](CC[C@H](N)C([O-])=O)C)O[C@H]1N1C2=NC=NC(N)=C2N=C1 MEFKEPWMEQBLKI-AIRLBKTGSA-N 0.000 description 1
• 102100026115 S-adenosylmethionine synthase isoform type-1 Human genes 0.000 description 1
• 102100034187 S-methyl-5'-thioadenosine phosphorylase Human genes 0.000 description 1
• 101710136206 S-methyl-5'-thioadenosine phosphorylase Proteins 0.000 description 1
• 102000042852 S6 kinase family Human genes 0.000 description 1
• 108091082205 S6 kinase family Proteins 0.000 description 1
• 201000010208 Seminoma Diseases 0.000 description 1
• LDEBVRIURYMKQS-WISUUJSJSA-N Ser-Thr Chemical compound C[C@@H](O)[C@@H](C(O)=O)NC(=O)[C@@H](N)CO LDEBVRIURYMKQS-WISUUJSJSA-N 0.000 description 1
• MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 1
• 108010022999 Serine Proteases Proteins 0.000 description 1
• 102000012479 Serine Proteases Human genes 0.000 description 1
• 102000019394 Serine hydroxymethyltransferases Human genes 0.000 description 1
• 101710108318 Serine/threonine-protein kinase 17B Proteins 0.000 description 1
• 102100028904 Serine/threonine-protein kinase MARK2 Human genes 0.000 description 1
• 208000002669 Sex Cord-Gonadal Stromal Tumors Diseases 0.000 description 1
• 102000003838 Sialyltransferases Human genes 0.000 description 1
• 108090000141 Sialyltransferases Proteins 0.000 description 1
• 101150054344 Smarca4 gene Proteins 0.000 description 1
• 102000001494 Sterol O-Acyltransferase Human genes 0.000 description 1
• 108010054082 Sterol O-acyltransferase Proteins 0.000 description 1
• 208000005718 Stomach Neoplasms Diseases 0.000 description 1
• 101710135785 Subtilisin-like protease Proteins 0.000 description 1
• 108010012901 Succinate Dehydrogenase Proteins 0.000 description 1
• 102000005262 Sulfatase Human genes 0.000 description 1
• 102000004896 Sulfotransferases Human genes 0.000 description 1
• 108090001033 Sulfotransferases Proteins 0.000 description 1
• 206010057644 Testis cancer Diseases 0.000 description 1
• BHEOSNUKNHRBNM-UHFFFAOYSA-N Tetramethylsqualene Natural products CC(=C)C(C)CCC(=C)C(C)CCC(C)=CCCC=C(C)CCC(C)C(=C)CCC(C)C(C)=C BHEOSNUKNHRBNM-UHFFFAOYSA-N 0.000 description 1
• 102000012463 Thioesterase domains Human genes 0.000 description 1
• 108050002018 Thioesterase domains Proteins 0.000 description 1
• 102000002932 Thiolase Human genes 0.000 description 1
• 108060008225 Thiolase Proteins 0.000 description 1
• 108090000958 Thiopurine S-methyltransferases Proteins 0.000 description 1
• 102000004377 Thiopurine S-methyltransferases Human genes 0.000 description 1
• 108010006873 Threonine Dehydratase Proteins 0.000 description 1
• 102000006601 Thymidine Kinase Human genes 0.000 description 1
• 108020004440 Thymidine kinase Proteins 0.000 description 1
• 102000005497 Thymidylate Synthase Human genes 0.000 description 1
• 108020004530 Transaldolase Proteins 0.000 description 1
• 102100028601 Transaldolase Human genes 0.000 description 1
• 101710150448 Transcriptional regulator Myc Proteins 0.000 description 1
• 102000004887 Transforming Growth Factor beta Human genes 0.000 description 1
• 108090001012 Transforming Growth Factor beta Proteins 0.000 description 1
• 102100029677 Trehalase Human genes 0.000 description 1
• 108010087472 Trehalase Proteins 0.000 description 1
• 102000005924 Triose-Phosphate Isomerase Human genes 0.000 description 1
• 108700015934 Triose-phosphate isomerases Proteins 0.000 description 1
• 102000044209 Tumor Suppressor Genes Human genes 0.000 description 1
• 108700025716 Tumor Suppressor Genes Proteins 0.000 description 1
• 108010040002 Tumor Suppressor Proteins Proteins 0.000 description 1
• 102000001742 Tumor Suppressor Proteins Human genes 0.000 description 1
• 102000014384 Type C Phospholipases Human genes 0.000 description 1
• 108010079194 Type C Phospholipases Proteins 0.000 description 1
• 102000004517 UDP-glucose/GDP-mannose dehydrogenase Human genes 0.000 description 1
• 108020001896 UDP-glucose/GDP-mannose dehydrogenase Proteins 0.000 description 1
• 101710100179 UMP-CMP kinase Proteins 0.000 description 1
• 101710119674 UMP-CMP kinase 2, mitochondrial Proteins 0.000 description 1
• 102000012469 UbiE/COQ5 methyltransferases Human genes 0.000 description 1
• 108050002049 UbiE/COQ5 methyltransferases Proteins 0.000 description 1
• 108010072685 Uracil-DNA Glycosidase Proteins 0.000 description 1
• 102000006943 Uracil-DNA Glycosidase Human genes 0.000 description 1
• 102100038442 Uridine-cytidine kinase 1 Human genes 0.000 description 1
• 108050006046 Uridine-cytidine kinase 1 Proteins 0.000 description 1
• 208000006105 Uterine Cervical Neoplasms Diseases 0.000 description 1
• 101710100604 Valine dehydrogenase Proteins 0.000 description 1
• 108010003205 Vasoactive Intestinal Peptide Proteins 0.000 description 1
• 102400000015 Vasoactive intestinal peptide Human genes 0.000 description 1
• 208000014070 Vestibular schwannoma Diseases 0.000 description 1
• 229930003779 Vitamin B12 Natural products 0.000 description 1
• 101710133062 Vitamin K-dependent gamma-carboxylase Proteins 0.000 description 1
• 102100038182 Vitamin K-dependent gamma-carboxylase Human genes 0.000 description 1
• 208000032810 X-linked dominant chondrodysplasia punctata Diseases 0.000 description 1
• 101710149909 Zinc carboxypeptidase Proteins 0.000 description 1
• 102100024148 [Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 1, mitochondrial Human genes 0.000 description 1
• 238000009825 accumulation Methods 0.000 description 1
• 208000004064 acoustic neuroma Diseases 0.000 description 1
• 230000009471 action Effects 0.000 description 1
• 230000003213 activating effect Effects 0.000 description 1
• 239000012190 activator Substances 0.000 description 1
• 208000021841 acute erythroid leukemia Diseases 0.000 description 1
• UDMBCSSLTHHNCD-KQYNXXCUSA-N adenosine 5'-monophosphate Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](COP(O)(O)=O)[C@@H](O)[C@H]1O UDMBCSSLTHHNCD-KQYNXXCUSA-N 0.000 description 1
• 230000001919 adrenal effect Effects 0.000 description 1
• 239000000556 agonist Substances 0.000 description 1
• 125000003275 alpha amino acid group Chemical group 0.000 description 1
• 150000004716 alpha keto acids Chemical class 0.000 description 1
• 102000012086 alpha-L-Fucosidase Human genes 0.000 description 1
• 108010061314 alpha-L-Fucosidase Proteins 0.000 description 1
• 230000004075 alteration Effects 0.000 description 1
• 102000005922 amidase Human genes 0.000 description 1
• 150000001408 amides Chemical class 0.000 description 1
• 125000000539 amino acid group Chemical group 0.000 description 1
• 108010038083 amyloid fibril protein AS-SAM Proteins 0.000 description 1
• 239000005557 antagonist Substances 0.000 description 1
• 230000001093 anti-cancer Effects 0.000 description 1
• 230000002253 anti-ischaemic effect Effects 0.000 description 1
• 239000003963 antioxidant agent Substances 0.000 description 1
• 230000003078 antioxidant effect Effects 0.000 description 1
• 239000000074 antisense oligonucleotide Substances 0.000 description 1
• 238000012230 antisense oligonucleotides Methods 0.000 description 1
• 210000000709 aorta Anatomy 0.000 description 1
• 230000001640 apoptogenic effect Effects 0.000 description 1
• 230000006217 arginine-methylation Effects 0.000 description 1
• 229960003272 asparaginase Drugs 0.000 description 1
• DCXYFEDJOCDNAF-UHFFFAOYSA-M asparaginate Chemical compound [O-]C(=O)C(N)CC(N)=O DCXYFEDJOCDNAF-UHFFFAOYSA-M 0.000 description 1
• 229910052789 astatine Inorganic materials 0.000 description 1
• RYXHOMYVWAEKHL-UHFFFAOYSA-N astatine atom Chemical compound [At] RYXHOMYVWAEKHL-UHFFFAOYSA-N 0.000 description 1
• QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
• 230000002238 attenuated effect Effects 0.000 description 1
• 230000003190 augmentative effect Effects 0.000 description 1
• 230000003376 axonal effect Effects 0.000 description 1
• 230000001580 bacterial effect Effects 0.000 description 1
• IQFYYKKMVGJFEH-UHFFFAOYSA-N beta-L-thymidine Natural products O=C1NC(=O)C(C)=CN1C1OC(CO)C(O)C1 IQFYYKKMVGJFEH-UHFFFAOYSA-N 0.000 description 1
• 102000004558 biliverdin reductase Human genes 0.000 description 1
• 230000001851 biosynthetic effect Effects 0.000 description 1
• 229960002685 biotin Drugs 0.000 description 1
• 235000020958 biotin Nutrition 0.000 description 1
• 239000011616 biotin Substances 0.000 description 1
• 201000001531 bladder carcinoma Diseases 0.000 description 1
• 210000004958 brain cell Anatomy 0.000 description 1
• 150000005693 branched-chain amino acids Chemical class 0.000 description 1
• 201000005389 breast carcinoma in situ Diseases 0.000 description 1
• 201000003149 breast fibroadenoma Diseases 0.000 description 1
• 208000003362 bronchogenic carcinoma Diseases 0.000 description 1
• 102100029387 cAMP-responsive element modulator Human genes 0.000 description 1
• 239000011575 calcium Substances 0.000 description 1
• 229910052791 calcium Inorganic materials 0.000 description 1
• AIXAANGOTKPUOY-UHFFFAOYSA-N carbachol Chemical compound [Cl-].C[N+](C)(C)CCOC(N)=O AIXAANGOTKPUOY-UHFFFAOYSA-N 0.000 description 1
• 229960004484 carbachol Drugs 0.000 description 1
• 229910052799 carbon Inorganic materials 0.000 description 1
• 239000001569 carbon dioxide Substances 0.000 description 1
• 229910002092 carbon dioxide Inorganic materials 0.000 description 1
• 238000006473 carboxylation reaction Methods 0.000 description 1
• 208000002458 carcinoid tumor Diseases 0.000 description 1
• 229960004203 carnitine Drugs 0.000 description 1
• 210000000845 cartilage Anatomy 0.000 description 1
• 125000002091 cationic group Chemical group 0.000 description 1
• 230000005779 cell damage Effects 0.000 description 1
• 230000032823 cell division Effects 0.000 description 1
• 230000012292 cell migration Effects 0.000 description 1
• 230000003822 cell turnover Effects 0.000 description 1
• 230000033077 cellular process Effects 0.000 description 1
• 230000036755 cellular response Effects 0.000 description 1
• 230000004637 cellular stress Effects 0.000 description 1
• 210000003850 cellular structure Anatomy 0.000 description 1
• 210000002230 centromere Anatomy 0.000 description 1
• 201000010881 cervical cancer Diseases 0.000 description 1
• 230000008859 change Effects 0.000 description 1
• 238000012512 characterization method Methods 0.000 description 1
• 230000009920 chelation Effects 0.000 description 1
• 239000003795 chemical substances by application Substances 0.000 description 1
• 208000006990 cholangiocarcinoma Diseases 0.000 description 1
• 235000012000 cholesterol Nutrition 0.000 description 1
• 208000001020 chondrodysplasia punctata Diseases 0.000 description 1
• 230000024321 chromosome segregation Effects 0.000 description 1
• 230000001684 chronic effect Effects 0.000 description 1
• 208000019425 cirrhosis of liver Diseases 0.000 description 1
• AGVAZMGAQJOSFJ-WZHZPDAFSA-M cobalt(2+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+2].N#[C-].[N-]([C@@H]1[C@H](CC(N)=O)[C@@]2(C)CCC(=O)NC[C@@H](C)OP(O)(=O)O[C@H]3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)\C2=C(C)/C([C@H](C\2(C)C)CCC(N)=O)=N/C/2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O AGVAZMGAQJOSFJ-WZHZPDAFSA-M 0.000 description 1
• RGJOEKWQDUBAIZ-UHFFFAOYSA-N coenzime A Natural products OC1C(OP(O)(O)=O)C(COP(O)(=O)OP(O)(=O)OCC(C)(C)C(O)C(=O)NCCC(=O)NCCS)OC1N1C2=NC=NC(N)=C2N=C1 RGJOEKWQDUBAIZ-UHFFFAOYSA-N 0.000 description 1
• 239000005515 coenzyme Substances 0.000 description 1
• 239000005516 coenzyme A Substances 0.000 description 1
• 229940093530 coenzyme a Drugs 0.000 description 1
• 230000004732 colorectal carcinogenesis Effects 0.000 description 1
• 208000016576 colorectal neuroendocrine tumor G1 Diseases 0.000 description 1
• 238000004891 communication Methods 0.000 description 1
• 239000002299 complementary DNA Substances 0.000 description 1
• 239000003636 conditioned culture medium Substances 0.000 description 1
• 230000001276 controlling effect Effects 0.000 description 1
• 238000012937 correction Methods 0.000 description 1
• 229940111134 coxibs Drugs 0.000 description 1
• 101150071119 cpg-2 gene Proteins 0.000 description 1
• 125000004122 cyclic group Chemical group 0.000 description 1
• 208000002445 cystadenocarcinoma Diseases 0.000 description 1
• 208000007321 cystadenofibroma Diseases 0.000 description 1
• 230000010250 cytokine signaling pathway Effects 0.000 description 1
• 230000003436 cytoskeletal effect Effects 0.000 description 1
• 230000006378 damage Effects 0.000 description 1
• 230000000254 damaging effect Effects 0.000 description 1
• 230000006196 deacetylation Effects 0.000 description 1
• 238000003381 deacetylation reaction Methods 0.000 description 1
• 230000007547 defect Effects 0.000 description 1
• 230000007812 deficiency Effects 0.000 description 1
• 230000002950 deficient Effects 0.000 description 1
• 238000006356 dehydrogenation reaction Methods 0.000 description 1
• 238000012217 deletion Methods 0.000 description 1
• 230000037430 deletion Effects 0.000 description 1
• KDTSHFARGAKYJN-UHFFFAOYSA-N dephosphocoenzyme A Natural products OC1C(O)C(COP(O)(=O)OP(O)(=O)OCC(C)(C)C(O)C(=O)NCCC(=O)NCCS)OC1N1C2=NC=NC(N)=C2N=C1 KDTSHFARGAKYJN-UHFFFAOYSA-N 0.000 description 1
• 238000013461 design Methods 0.000 description 1
• 238000001784 detoxification Methods 0.000 description 1
• 235000005911 diet Nutrition 0.000 description 1
• 230000000378 dietary effect Effects 0.000 description 1
• 239000000539 dimer Substances 0.000 description 1
• 239000001177 diphosphate Substances 0.000 description 1
• XPPKVPWEQAFLFU-UHFFFAOYSA-J diphosphate(4-) Chemical compound [O-]P([O-])(=O)OP([O-])([O-])=O XPPKVPWEQAFLFU-UHFFFAOYSA-J 0.000 description 1
• XPPKVPWEQAFLFU-UHFFFAOYSA-N diphosphoric acid Chemical compound OP(O)(=O)OP(O)(O)=O XPPKVPWEQAFLFU-UHFFFAOYSA-N 0.000 description 1
• 230000007646 directional migration Effects 0.000 description 1
• 230000008034 disappearance Effects 0.000 description 1
• 101150042537 dld1 gene Proteins 0.000 description 1
• PRAKJMSDJKAYCZ-UHFFFAOYSA-N dodecahydrosqualene Natural products CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 1
• 230000003828 downregulation Effects 0.000 description 1
• 230000007783 downstream signaling Effects 0.000 description 1
• 208000028715 ductal breast carcinoma in situ Diseases 0.000 description 1
• 201000007273 ductal carcinoma in situ Diseases 0.000 description 1
• 230000001516 effect on protein Effects 0.000 description 1
• 239000012636 effector Substances 0.000 description 1
• 210000001900 endoderm Anatomy 0.000 description 1
• 230000002357 endometrial effect Effects 0.000 description 1
• 210000004696 endometrium Anatomy 0.000 description 1
• 230000010595 endothelial cell migration Effects 0.000 description 1
• 239000002158 endotoxin Substances 0.000 description 1
• 230000002708 enhancing effect Effects 0.000 description 1
• 102000003630 enoyl-CoA hydratase/isomerase Human genes 0.000 description 1
• 108020000862 enoyl-CoA hydratase/isomerase Proteins 0.000 description 1
• 230000009088 enzymatic function Effects 0.000 description 1
• 229940116977 epidermal growth factor Drugs 0.000 description 1
• 201000004101 esophageal cancer Diseases 0.000 description 1
• 150000002148 esters Chemical class 0.000 description 1
• 210000004265 eukaryotic small ribosome subunit Anatomy 0.000 description 1
• 230000003492 excitotoxic effect Effects 0.000 description 1
• 231100000063 excitotoxicity Toxicity 0.000 description 1
• 230000001747 exhibiting effect Effects 0.000 description 1
• 210000002950 fibroblast Anatomy 0.000 description 1
• 206010016629 fibroma Diseases 0.000 description 1
• 230000004761 fibrosis Effects 0.000 description 1
• 230000003176 fibrotic effect Effects 0.000 description 1
• 229940014144 folate Drugs 0.000 description 1
• OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 1
• 235000019152 folic acid Nutrition 0.000 description 1
• 239000011724 folic acid Substances 0.000 description 1
• 102000037865 fusion proteins Human genes 0.000 description 1
• 108020001507 fusion proteins Proteins 0.000 description 1
• 102000006640 gamma-Glutamyltransferase Human genes 0.000 description 1
• 208000010749 gastric carcinoma Diseases 0.000 description 1
• 230000002496 gastric effect Effects 0.000 description 1
• 230000023266 generation of precursor metabolites and energy Effects 0.000 description 1
• 208000016361 genetic disease Diseases 0.000 description 1
• 230000000762 glandular Effects 0.000 description 1
• 230000004110 gluconeogenesis Effects 0.000 description 1
• 108010022717 glucosamine-6-phosphate isomerase Proteins 0.000 description 1
• 125000000291 glutamic acid group Chemical group N[C@@H](CCC(O)=O)C(=O)* 0.000 description 1
• 102000005396 glutamine synthetase Human genes 0.000 description 1
• 108020002326 glutamine synthetase Proteins 0.000 description 1
• 210000004517 glycocalyx Anatomy 0.000 description 1
• 229940096919 glycogen Drugs 0.000 description 1
• 125000003147 glycosyl group Chemical group 0.000 description 1
• 230000002710 gonadal effect Effects 0.000 description 1
• 239000008187 granular material Substances 0.000 description 1
• 210000000020 growth cone Anatomy 0.000 description 1
• 201000000079 gynecomastia Diseases 0.000 description 1
• 208000024963 hair loss Diseases 0.000 description 1
• 230000003676 hair loss Effects 0.000 description 1
• LNEPOXFFQSENCJ-UHFFFAOYSA-N haloperidol Chemical compound C1CC(O)(C=2C=CC(Cl)=CC=2)CCN1CCCC(=O)C1=CC=C(F)C=C1 LNEPOXFFQSENCJ-UHFFFAOYSA-N 0.000 description 1
• 201000010536 head and neck cancer Diseases 0.000 description 1
• 208000014829 head and neck neoplasm Diseases 0.000 description 1
• 230000035876 healing Effects 0.000 description 1
• 201000002222 hemangioblastoma Diseases 0.000 description 1
• 231100000844 hepatocellular carcinoma Toxicity 0.000 description 1
• 210000001320 hippocampus Anatomy 0.000 description 1
• 230000013632 homeostatic process Effects 0.000 description 1
• 230000003054 hormonal effect Effects 0.000 description 1
• 102000055337 human MAPK7 Human genes 0.000 description 1
• 102000050356 human PAK6 Human genes 0.000 description 1
• 229960002773 hyaluronidase Drugs 0.000 description 1
• 238000009396 hybridization Methods 0.000 description 1
• 208000017819 hyperplastic polyp Diseases 0.000 description 1
• 230000001146 hypoxic effect Effects 0.000 description 1
• 210000000987 immune system Anatomy 0.000 description 1
• 230000006882 induction of apoptosis Effects 0.000 description 1
• 230000001939 inductive effect Effects 0.000 description 1
• 239000000543 intermediate Substances 0.000 description 1
• 230000037041 intracellular level Effects 0.000 description 1
• 230000010189 intracellular transport Effects 0.000 description 1
• 206010073095 invasive ductal breast carcinoma Diseases 0.000 description 1
• 201000010985 invasive ductal carcinoma Diseases 0.000 description 1
• 206010073096 invasive lobular breast carcinoma Diseases 0.000 description 1
• PGHMRUGBZOYCAA-ADZNBVRBSA-N ionomycin Chemical compound O1[C@H](C[C@H](O)[C@H](C)[C@H](O)[C@H](C)/C=C/C[C@@H](C)C[C@@H](C)C(/O)=C/C(=O)[C@@H](C)C[C@@H](C)C[C@@H](CCC(O)=O)C)CC[C@@]1(C)[C@@H]1O[C@](C)([C@@H](C)O)CC1 PGHMRUGBZOYCAA-ADZNBVRBSA-N 0.000 description 1
• PGHMRUGBZOYCAA-UHFFFAOYSA-N ionomycin Natural products O1C(CC(O)C(C)C(O)C(C)C=CCC(C)CC(C)C(O)=CC(=O)C(C)CC(C)CC(CCC(O)=O)C)CCC1(C)C1OC(C)(C(C)O)CC1 PGHMRUGBZOYCAA-UHFFFAOYSA-N 0.000 description 1
• ODBLHEXUDAPZAU-UHFFFAOYSA-N isocitric acid Chemical compound OC(=O)C(O)C(C(O)=O)CC(O)=O ODBLHEXUDAPZAU-UHFFFAOYSA-N 0.000 description 1
• 210000001630 jejunum Anatomy 0.000 description 1
• 210000003292 kidney cell Anatomy 0.000 description 1
• 238000000021 kinase assay Methods 0.000 description 1
• 238000011813 knockout mouse model Methods 0.000 description 1
• 229940029872 leucine / phenylalanine Drugs 0.000 description 1
• 108010004145 leukotriene B4 12-hydroxydehydrogenase Proteins 0.000 description 1
• 239000003913 leukotriene B4 receptor antagonist Substances 0.000 description 1
• 150000002617 leukotrienes Chemical class 0.000 description 1
• 230000037356 lipid metabolism Effects 0.000 description 1
• 229920006008 lipopolysaccharide Polymers 0.000 description 1
• 206010024627 liposarcoma Diseases 0.000 description 1
• 201000007270 liver cancer Diseases 0.000 description 1
• 201000011059 lobular neoplasia Diseases 0.000 description 1
• 150000004668 long chain fatty acids Chemical class 0.000 description 1
• 210000005265 lung cell Anatomy 0.000 description 1
• 208000037829 lymphangioendotheliosarcoma Diseases 0.000 description 1
• 230000002132 lysosomal effect Effects 0.000 description 1
• 210000003712 lysosome Anatomy 0.000 description 1
• 230000001868 lysosomic effect Effects 0.000 description 1
• 108010026228 mRNA guanylyltransferase Proteins 0.000 description 1
• 102100039604 mRNA guanylyltransferase Human genes 0.000 description 1
• 238000012423 maintenance Methods 0.000 description 1
• 208000006178 malignant mesothelioma Diseases 0.000 description 1
• 208000027202 mammary Paget disease Diseases 0.000 description 1
• 239000003550 marker Substances 0.000 description 1
• 238000005259 measurement Methods 0.000 description 1
• 230000021121 meiosis Effects 0.000 description 1
• 230000009061 membrane transport Effects 0.000 description 1
• 206010027191 meningioma Diseases 0.000 description 1
• 230000037353 metabolic pathway Effects 0.000 description 1
• 239000002207 metabolite Substances 0.000 description 1
• 229930182817 methionine Natural products 0.000 description 1
• 239000002395 mineralocorticoid Substances 0.000 description 1
• 230000022886 mitochondrial translation Effects 0.000 description 1
• 210000001616 monocyte Anatomy 0.000 description 1
• 201000002335 monodermal teratoma Diseases 0.000 description 1
• 108091006026 monomeric small GTPases Proteins 0.000 description 1
• 239000003471 mutagenic agent Substances 0.000 description 1
• 231100000707 mutagenic chemical Toxicity 0.000 description 1
• 231100000243 mutagenic effect Toxicity 0.000 description 1
• NJHLGKJQFKUSEA-UHFFFAOYSA-N n-[2-(4-hydroxyphenyl)ethyl]-n-methylnitrous amide Chemical compound O=NN(C)CCC1=CC=C(O)C=C1 NJHLGKJQFKUSEA-UHFFFAOYSA-N 0.000 description 1
• 208000025189 neoplasm of testis Diseases 0.000 description 1
• 208000012108 neoplastic polyp Diseases 0.000 description 1
• 208000029522 neoplastic syndrome Diseases 0.000 description 1
• 201000011519 neuroendocrine tumor Diseases 0.000 description 1
• 230000002232 neuromuscular Effects 0.000 description 1
• 230000003961 neuronal insult Effects 0.000 description 1
• 229930027945 nicotinamide-adenine dinucleotide Natural products 0.000 description 1
• BOPGDPNILDQYTO-NNYOXOHSSA-N nicotinamide-adenine dinucleotide Chemical compound C1=CCC(C(=O)N)=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OC[C@@H]2[C@H]([C@@H](O)[C@@H](O2)N2C3=NC=NC(N)=C3N=C2)O)O1 BOPGDPNILDQYTO-NNYOXOHSSA-N 0.000 description 1
• 108020001162 nitroreductase Proteins 0.000 description 1
• 239000002777 nucleoside Substances 0.000 description 1
• 108010027581 nucleoside triphosphate pyrophosphatase Proteins 0.000 description 1
• 108010067588 nucleotide pyrophosphatase Proteins 0.000 description 1
• 235000015097 nutrients Nutrition 0.000 description 1
• 201000008106 ocular cancer Diseases 0.000 description 1
• 231100000590 oncogenic Toxicity 0.000 description 1
• 230000002246 oncogenic effect Effects 0.000 description 1
• 238000011275 oncology therapy Methods 0.000 description 1
• 210000000056 organ Anatomy 0.000 description 1
• 210000003463 organelle Anatomy 0.000 description 1
• FKCRAVPPBFWEJD-UHFFFAOYSA-N orotidine Natural products OC1C(O)C(CO)OC1N1C(=O)NC(=O)C=C1C(O)=O FKCRAVPPBFWEJD-UHFFFAOYSA-N 0.000 description 1
• FKCRAVPPBFWEJD-XVFCMESISA-N orotidine Chemical compound O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C=C1C(O)=O FKCRAVPPBFWEJD-XVFCMESISA-N 0.000 description 1
• 230000004072 osteoblast differentiation Effects 0.000 description 1
• 201000008968 osteosarcoma Diseases 0.000 description 1
• 208000025207 ovarian monodermal teratoma Diseases 0.000 description 1
• 108010058266 p21-Activated Kinases Proteins 0.000 description 1
• 102000006271 p21-Activated Kinases Human genes 0.000 description 1
• 208000004019 papillary adenocarcinoma Diseases 0.000 description 1
• 102000041768 paraoxonase family Human genes 0.000 description 1
• 108091075668 paraoxonase family Proteins 0.000 description 1
• 230000036961 partial effect Effects 0.000 description 1
• 230000008506 pathogenesis Effects 0.000 description 1
• 230000007170 pathology Effects 0.000 description 1
• 210000003668 pericyte Anatomy 0.000 description 1
• 230000002085 persistent effect Effects 0.000 description 1
• 101150100557 pfkB gene Proteins 0.000 description 1
• 230000000144 pharmacologic effect Effects 0.000 description 1
• COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 1
• 239000002644 phorbol ester Substances 0.000 description 1
• NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
• 239000010452 phosphate Substances 0.000 description 1
• 150000008103 phosphatidic acids Chemical class 0.000 description 1
• WTJKGGKOPKCXLL-RRHRGVEJSA-N phosphatidylcholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCCC=CCCCCCCCC WTJKGGKOPKCXLL-RRHRGVEJSA-N 0.000 description 1
• 239000002935 phosphatidylinositol 3 kinase inhibitor Substances 0.000 description 1
• 229930029653 phosphoenolpyruvate Natural products 0.000 description 1
• 229940043441 phosphoinositide 3-kinase inhibitor Drugs 0.000 description 1
• 150000003904 phospholipids Chemical class 0.000 description 1
• DTBNBXWJWCWCIK-UHFFFAOYSA-K phosphonatoenolpyruvate Chemical compound [O-]C(=O)C(=C)OP([O-])([O-])=O DTBNBXWJWCWCIK-UHFFFAOYSA-K 0.000 description 1
• 108010034343 phosphoribosylamine-glycine ligase Proteins 0.000 description 1
• 108010035774 phosphoribosylaminoimidazole carboxylase Proteins 0.000 description 1
• 238000005222 photoaffinity labeling Methods 0.000 description 1
• 208000024724 pineal body neoplasm Diseases 0.000 description 1
• 229940127126 plasminogen activator Drugs 0.000 description 1
• 239000004033 plastic Substances 0.000 description 1
• 229920003023 plastic Polymers 0.000 description 1
• 201000003437 pleural cancer Diseases 0.000 description 1
• 201000003144 pneumothorax Diseases 0.000 description 1
• 239000001205 polyphosphate Substances 0.000 description 1
• 235000011176 polyphosphates Nutrition 0.000 description 1
• 229920001282 polysaccharide Polymers 0.000 description 1
• 239000005017 polysaccharide Substances 0.000 description 1
• 150000004804 polysaccharides Chemical class 0.000 description 1
• 150000004032 porphyrins Chemical class 0.000 description 1
• 230000029279 positive regulation of transcription, DNA-dependent Effects 0.000 description 1
• 230000004481 post-translational protein modification Effects 0.000 description 1
• 230000003389 potentiating effect Effects 0.000 description 1
• 239000002243 precursor Substances 0.000 description 1
• 125000001844 prenyl group Chemical group [H]C([*])([H])C([H])=C(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
• 230000002265 prevention Effects 0.000 description 1
• 238000004393 prognosis Methods 0.000 description 1
• 208000035803 proliferative type breast fibrocystic change Diseases 0.000 description 1
• 230000001737 promoting effect Effects 0.000 description 1
• KCXFHTAICRTXLI-UHFFFAOYSA-N propane-1-sulfonic acid Chemical compound CCCS(O)(=O)=O KCXFHTAICRTXLI-UHFFFAOYSA-N 0.000 description 1
• 201000005825 prostate adenocarcinoma Diseases 0.000 description 1
• 210000000064 prostate epithelial cell Anatomy 0.000 description 1
• 235000019833 protease Nutrition 0.000 description 1
• 238000001243 protein synthesis Methods 0.000 description 1
• 230000004850 protein–protein interaction Effects 0.000 description 1
• 230000017854 proteolysis Effects 0.000 description 1
• 229940024999 proteolytic enzymes for treatment of wounds and ulcers Drugs 0.000 description 1
• 239000002212 purine nucleoside Substances 0.000 description 1
• 150000003222 pyridines Chemical class 0.000 description 1
• 235000008160 pyridoxine Nutrition 0.000 description 1
• 239000011677 pyridoxine Substances 0.000 description 1
• 108010042660 rRNA (adenosine-O-2'-)methyltransferase Proteins 0.000 description 1
• 108010065206 ras-GRF1 Proteins 0.000 description 1
• 238000009790 rate-determining step (RDS) Methods 0.000 description 1
• 238000003753 real-time PCR Methods 0.000 description 1
• 206010038038 rectal cancer Diseases 0.000 description 1
• 201000001275 rectum cancer Diseases 0.000 description 1
• 230000022983 regulation of cell cycle Effects 0.000 description 1
• 230000025053 regulation of cell proliferation Effects 0.000 description 1
• 230000026267 regulation of growth Effects 0.000 description 1
• 230000022532 regulation of transcription, DNA-dependent Effects 0.000 description 1
• 238000007634 remodeling Methods 0.000 description 1
• 230000033458 reproduction Effects 0.000 description 1
• 230000027756 respiratory electron transport chain Effects 0.000 description 1
• 230000028617 response to DNA damage stimulus Effects 0.000 description 1
• 230000011506 response to oxidative stress Effects 0.000 description 1
• 238000012552 review Methods 0.000 description 1
• 201000009410 rhabdomyosarcoma Diseases 0.000 description 1
• 210000003705 ribosome Anatomy 0.000 description 1
• 108020000318 saccharopine dehydrogenase Proteins 0.000 description 1
• 201000008407 sebaceous adenocarcinoma Diseases 0.000 description 1
• 201000007321 sebaceous carcinoma Diseases 0.000 description 1
• 208000028467 sex cord-stromal tumor Diseases 0.000 description 1
• 108010085082 sigma receptors Proteins 0.000 description 1
• 238000005549 size reduction Methods 0.000 description 1
• 210000002363 skeletal muscle cell Anatomy 0.000 description 1
• 201000000849 skin cancer Diseases 0.000 description 1
• 102000030938 small GTPase Human genes 0.000 description 1
• 239000000600 sorbitol Substances 0.000 description 1
• 241000894007 species Species 0.000 description 1
• 210000001032 spinal nerve Anatomy 0.000 description 1
• 210000000952 spleen Anatomy 0.000 description 1
• 229940031439 squalene Drugs 0.000 description 1
• TUHBEKDERLKLEC-UHFFFAOYSA-N squalene Natural products CC(=CCCC(=CCCC(=CCCC=C(/C)CCC=C(/C)CC=C(C)C)C)C)C TUHBEKDERLKLEC-UHFFFAOYSA-N 0.000 description 1
• 239000003270 steroid hormone Substances 0.000 description 1
• 102000005969 steroid hormone receptors Human genes 0.000 description 1
• 108020003113 steroid hormone receptors Proteins 0.000 description 1
• 201000011549 stomach cancer Diseases 0.000 description 1
• 201000000498 stomach carcinoma Diseases 0.000 description 1
• 235000000346 sugar Nutrition 0.000 description 1
• 150000008163 sugars Chemical class 0.000 description 1
• 238000006277 sulfonation reaction Methods 0.000 description 1
• MLKXDPUZXIRXEP-MFOYZWKCSA-N sulindac Chemical compound CC1=C(CC(O)=O)C2=CC(F)=CC=C2\C1=C/C1=CC=C(S(C)=O)C=C1 MLKXDPUZXIRXEP-MFOYZWKCSA-N 0.000 description 1
• 229960000894 sulindac Drugs 0.000 description 1
• 230000009469 supplementation Effects 0.000 description 1
• 230000001629 suppression Effects 0.000 description 1
• 230000002459 sustained effect Effects 0.000 description 1
• 230000008961 swelling Effects 0.000 description 1
• 230000001360 synchronised effect Effects 0.000 description 1
• 208000011580 syndromic disease Diseases 0.000 description 1
• 206010042863 synovial sarcoma Diseases 0.000 description 1
• 238000003786 synthesis reaction Methods 0.000 description 1
• 229940037128 systemic glucocorticoids Drugs 0.000 description 1
• 108010066587 tRNA Methyltransferases Proteins 0.000 description 1
• 102000018477 tRNA Methyltransferases Human genes 0.000 description 1
• 108091064493 tRNA uridine Proteins 0.000 description 1
• 230000002123 temporal effect Effects 0.000 description 1
• 210000001550 testis Anatomy 0.000 description 1
• ZRKFYGHZFMAOKI-QMGMOQQFSA-N tgfbeta Chemical compound C([C@H](NC(=O)[C@H](C(C)C)NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCSC)C(C)C)[C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](C)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N1[C@@H](CCC1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(O)=O)C1=CC=C(O)C=C1 ZRKFYGHZFMAOKI-QMGMOQQFSA-N 0.000 description 1
• 229940104230 thymidine Drugs 0.000 description 1
• 210000001541 thymus gland Anatomy 0.000 description 1
• 239000003053 toxin Substances 0.000 description 1
• 231100000765 toxin Toxicity 0.000 description 1
• 108700012359 toxins Proteins 0.000 description 1
• 230000037426 transcriptional repression Effects 0.000 description 1
• 230000014621 translational initiation Effects 0.000 description 1
• 108010020589 trehalose-6-phosphate synthase Proteins 0.000 description 1
• UNXRWKVEANCORM-UHFFFAOYSA-N triphosphoric acid Chemical compound OP(O)(=O)OP(O)(=O)OP(O)(O)=O UNXRWKVEANCORM-UHFFFAOYSA-N 0.000 description 1
• 201000007423 tubular adenocarcinoma Diseases 0.000 description 1
• 208000025421 tumor of uterus Diseases 0.000 description 1
• 230000005760 tumorsuppression Effects 0.000 description 1
• 230000007306 turnover Effects 0.000 description 1
• 229940035936 ubiquinone Drugs 0.000 description 1
• 238000009281 ultraviolet germicidal irradiation Methods 0.000 description 1
• 208000010570 urinary bladder carcinoma Diseases 0.000 description 1
• VBEQCZHXXJYVRD-GACYYNSASA-N uroanthelone Chemical compound C([C@@H](C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O)C(C)C)[C@@H](C)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](NC(=O)[C@H](CC=1NC=NC=1)NC(=O)[C@H](CCSC)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)CNC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CS)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CS)NC(=O)CNC(=O)[C@H]1N(CCC1)C(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC(N)=O)C(C)C)[C@@H](C)CC)C1=CC=C(O)C=C1 VBEQCZHXXJYVRD-GACYYNSASA-N 0.000 description 1
• 210000004291 uterus Anatomy 0.000 description 1
• 210000005166 vasculature Anatomy 0.000 description 1
• 239000003981 vehicle Substances 0.000 description 1
• 230000002861 ventricular Effects 0.000 description 1
• 210000000264 venule Anatomy 0.000 description 1
• 108700026220 vif Genes Proteins 0.000 description 1
• 229940088594 vitamin Drugs 0.000 description 1
• 229930003231 vitamin Natural products 0.000 description 1
• 235000013343 vitamin Nutrition 0.000 description 1
• 239000011782 vitamin Substances 0.000 description 1
• 235000019163 vitamin B12 Nutrition 0.000 description 1
• 239000011715 vitamin B12 Substances 0.000 description 1
• 150000003722 vitamin derivatives Chemical class 0.000 description 1
• 239000002699 waste material Substances 0.000 description 1
• QDLHCMPXEPAAMD-QAIWCSMKSA-N wortmannin Chemical compound C1([C@]2(C)C3=C(C4=O)OC=C3C(=O)O[C@@H]2COC)=C4[C@@H]2CCC(=O)[C@@]2(C)C[C@H]1OC(C)=O QDLHCMPXEPAAMD-QAIWCSMKSA-N 0.000 description 1
• QDLHCMPXEPAAMD-UHFFFAOYSA-N wortmannin Natural products COCC1OC(=O)C2=COC(C3=O)=C2C1(C)C1=C3C2CCC(=O)C2(C)CC1OC(C)=O QDLHCMPXEPAAMD-UHFFFAOYSA-N 0.000 description 1
• 230000029663 wound healing Effects 0.000 description 1